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Exploring Financial Incentives To Promote Adherence To Anti-Retroviral
Medications In People Living With Hiv/aids
Abstract
With the introduction of Highly Active Anti-Retro Viral Therapy (HAART), Human Immunodeficiency Virus
(HIV) infection has become a manageable chronic condition (Deeks, Lewin & Havlir, 2013). Research
suggests that if all HIV positive individuals could be identified and immediately started on HAART and if,
they maintained good adherence to the medication, the HIV/AIDS epidemic could be effectively controlled
and eventually eliminated (Granich, Gilks, Dye, De Cock & Williams, 2009). However, adherence to HAART
remains a challenge for those living with HIV and their health care providers (Nachega et al., 2012; Mills et
al., 2006). Efforts are underway to improve adherence to HAART among people living with HIV/AIDS
(Chaiyachati, Ogbuoji, Price, Suthar, Negussie & Barnighausen, 2014). Financial incentives have been
shown to be effective in improving adherence to HAART (Giles, Robalino, McColl, Sniehotta & Adams,
2014). However, the way financial incentives work to promote adherence behaviors in a clinical setting
needs to be better understood before large-scale interventions are developed using this tool. The present
study employed a Constructivist Grounded Theory approach (Charmaz, 2006) to qualitatively answer the
question: How does the provision of financial incentives affect the process of adherence to anti-retroviral
medication in individuals with HIV infection? The study was conducted at Housing Works, which is a
community based HIV service organization in New York City. The participants were recruited from an
adherence promotion intervention implemented by Housing Works, The Viral Load Suppression (VLS)
program, which used financial incentives along with other services to promote adherence. Results
indicate that there were symbolic and material aspects to the effects of financial incentives on motivation
to adhere to medication. The context specific facilitators of and barriers to adherence were both
influenced by financial incentives and the facilitating factors, in turn, influenced the effect of the
incentives. The implications of the results are discussed specifically with regards to theory development,
practice directives, policy recommendations and future directions for research in financial incentives to
promote adherence to HAART.
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ABSTRACT
EXPLORING FINANCIAL INCENTIVES TO PROMOTE
ADHERENCE TO ANTI-RETROVIRAL MEDICATIONS IN
PEOPLE LIVING WITH HIV/AIDS
Sambuddha Chaudhuri
Dr. Andrea Doyle
With the introduction of Highly Active Anti-Retro Viral Therapy (HAART), Human
Immunodeficiency Virus (HIV) infection has become a manageable chronic condition
(Deeks, Lewin & Havlir, 2013). Research suggests that if all HIV positive individuals
could be identified and immediately started on HAART and if, they maintained good
adherence to the medication, the HIV/AIDS epidemic could be effectively controlled
and eventually eliminated (Granich, Gilks, Dye, De Cock & Williams, 2009). However,
adherence to HAART remains a challenge for those living with HIV and their health
care providers (Nachega et al., 2012; Mills et al., 2006). Efforts are underway to
improve adherence to HAART among people living with HIV/AIDS (Chaiyachati,
Ogbuoji, Price, Suthar, Negussie & Barnighausen, 2014). Financial incentives have
been shown to be effective in improving adherence to HAART (Giles, Robalino,
McColl, Sniehotta & Adams, 2014). However, the way financial incentives work to
promote adherence behaviors in a clinical setting needs to be better understood before
large-scale interventions are developed using this tool. The present study employed a
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Constructivist Grounded Theory approach (Charmaz, 2006) to qualitatively answer the
question: How does the provision of financial incentives affect the process of adherence
to anti-retroviral medication in individuals with HIV infection? The study was
conducted at Housing Works, which is a community based HIV service organization in
New York City. The participants were recruited from an adherence promotion
intervention implemented by Housing Works, The Viral Load Suppression (VLS)
program, which used financial incentives along with other services to promote
adherence. Results indicate that there were symbolic and material aspects to the effects
of financial incentives on motivation to adhere to medication. The context specific
facilitators of and barriers to adherence were both influenced by financial incentives and
the facilitating factors, in turn, influenced the effect of the incentives. The implications
of the results are discussed specifically with regards to theory development, practice
directives, policy recommendations and future directions for research in financial
incentives to promote adherence to HAART.
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Chapter 1: The HIV Epidemic, Adherence to HAART and Financial Incentives
Introduction
Research has suggested that the HIV/AIDS epidemic can be effectively
controlled (reduction in mortality & morbidity and effectively end ongoing
transmission) if all individuals with HIV can be identified and they are started on and
adhere to anti-retroviral medication (Granich, Gilks, Dye, De Cock, & Williams,
2009).Over the last two decades , scholars have repeatedly found evidence that an early
start to Anti-Retroviral Therapy (ART) for HIV-positive persons leads to preservation
of immune function thereby maintaining health and well-being of the infected persons
along with significantly reduced risk of ongoing HIV transmissions (Günthard et
al.,2016; Marrazzo et al., 2014; Opravil et al.,2002;Hogg et al., 1998; Pallela et al.,
1998).These findings point to an exciting future for HIV prevention and treatment.
The long-term success of effective Highly Active Anti-Retroviral Therapy
(HAART) is, however, limited by the necessity of high levels of adherence to treatment
schedules. When patients adhere to less than 90% of the recommended doses, a steep
decline in the treatment response is observed (Gross, Bilker, Friedman & Strom,2001;
Sethi et al.,2003). Although newer, more potent regimens allow for lower levels of
adherence (Kobin &Sheth, 2011), yet non-adherence is highly correlated with mortality
in people living with HIV/AIDS (PLWHA) (Gordon, Gharibian, Chong & Chun, 2015;
Kahana, Rohan, Allison, Frazier & Drotar, 2013; Mugavero et al., 2009;Wood et al.,
2003).Several efforts are underway, to improve the adherence to anti-retroviral therapy,
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so PLWHA experience good quality of life, while at the same time ,the HIV epidemic is
effectively controlled. Financial incentive programs, peer group-based support
interventions and directly observed therapy are a few of the promising approaches to
tackle the problem of poor adherence among PLWHA (Kanters et al., 2017; Linnemayr
& Rice, 2016; Sabin et al.,2015; Mannheimer, & Hirsch-Moverman, 2015; Chaiyachati,
Ogbuoji, Price, Suthar, Negussie & Barnighausen, 2014).
This chapter will provide a brief overview of the history of HIV care in the USA
and the ways it has changed the manner in which Public Health and Medical Research
has responded to the crisis of epidemics. This will be followed by an account of how
adherence to the anti-retroviral medical regimes fits into this history of responses to
HIV epidemic and the challenges to adherence. The final section of this chapter will
explore the ways in which financial incentives can play a role in promoting adherence
in the fight against the HIV epidemic. The chapter will conclude by introducing the
question under study: how can we better understand the role of financial incentives in
the context of adherence and HIV clinical care?
History of HIV care in the USA
HIV history and activism have changed many of the ways public policy and
public health are practiced today. The early 1980s in the US witnessed the emergence of
a hitherto unknown syndrome that, at first, seemed to claim the lives of previously
healthy, mostly young homosexual men (Smith & Whiteside, 2010). In this climate of
confusion over a new disease, the rising number of deaths coupled with homophobia
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and the conservative turn in the national politics led to a moral panic about the “sinful”
lifestyle choices of gay men (De Wall, 2006). This new disease, or syndrome was
dubbed gay related immunodeficiency disease (GIRDS), suggestive of a causal link
between homosexual lifestyle and the degenerative disease (Fee & Krieger, 1993;
Patton, 2002). Gay men faced overt discrimination when they wanted to access health
services (Smith & Whiteside, 2010). However, in 1983 when the causal HIV virus was
discovered along with increased reporting of cases among women, children, and
transfusion recipients, it became apparent that this disease could affect anyone if they
had been exposed to the virus.
The gay community had recently consolidated some political and social leverage in
the immediate post-civil rights, sexual liberation decades of the 1960s and 70s. Faced
with this new scourge, various gay civil rights groups responded by organizing against
the resurgent stigma and discrimination in the wake of HIV/AIDS epidemic.
Recognizing the greater vulnerability of gay men towards the disease, activist groups
rejected the public health logic of quarantine and isolation of those infected
(Rosenbrock et al, 2000). It was argued that such moves would further marginalize
individuals and drive the epidemic underground. Instead, groups started advocating for
better health care and access to services for the afflicted. By mid 1980s it became clear
that HIV spread was associated with basic life giving and pleasurable acts of sexual
intimacy and that no one was, technically, immune from this yet intractable disease.
Furthermore, activist groups began to advocate for a social justice approach to HIV
which emphasized the social determinants of health and framed the risk of infection and
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resultant stigma as one that endangered the civil liberties of the affected citizens (Fee
&Krieger, 1993; Mann &Tarantola,1998). The force of these claims, together with the
panic of a generalized epidemic, led to the belief that an exceptional disease such as
AIDS needed exceptional response, resulting in what has been described as “AIDS
exceptionalism” (Bayer,1994). By the late 1980s, the AIDS movement had given birth
to the ACT UP coalition, that embodied the spirit of public health advocacy and AIDS
exceptionalism. It called for policies that ensured quick translation of bench research on
disease modifying drugs into easily available medication for HIV infected individuals
(Patton, 2002).
In the 1996, at the International AIDS conference in Vancouver, Canada, Highly
Active Anti-Retroviral Therapy (HAART) was launched. Since then HIV/AIDS have
been transformed from a fatal disease for which there was only symptomatic treatment,
to a condition that can be successfully managed with long term medication regimes
(Deeks, Lewin & Havlir, 2013; Smith & Whiteside, 2010). HAART has revolutionized
the clinical outcomes of HIV infection and the massive public health response of the
1980s and 1990s was mostly effective in averting the feared pandemic with new
infections falling from about 130,000 in 1984 to approximately 60,000 in 1991 to about
47,500 in 2010 (El-Sadre, Mayer & Hodder,2010; CDC, 2012). The incidence rates of
HIV had remained at about 50,000 infections per year since the mid-1990s in the United
States (CDC, 2012) with a slight decrease to in 2015 with a reported 39,513 new cases
(CDC,2017).
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It was expected that HAART, with its suppressive effects on viral replication,
would result in lower rates of new infection, but this goal has not yet been realized (ElSadre, Mayer & Hodder, 2010). Moreover, certain “high risk groups”, such as African
Americans, Latinos and gay and bisexual men of all races/ethnicities, continue to be
disproportionately affected by the disease. Cohen (1999) in her book “The Boundaries
of Blackness: AIDS and the breakdown of black politics” has documented how the
epidemic has been particularly devastating for African American communities in the
major US cities. The most vulnerable groups within the African American communities
such as gay men, injection drug users and low-income women have borne the brunt of
the disease (Cohen,1999). They had to fight the multiple marginalization stemming
from their positions of race, class, gender, and sexuality to secure services and promote
awareness about the epidemic. As the latest statistics prove, communities of color
continue to withstand the worst of the disease (CDC, 2012) and are in need for services
that meet their medical, social, and economic needs if this trend is to be reversed.
Thus, in the present decade, although much of the impetus behind the original
AIDS exceptionalism has dissipated, the social justice approach to dealing with the
epidemic is not yet redundant. There remain huge gaps with regards to implementing
better access and adherence to the improved medicines, with the aim of improving
quality of lives of PLWHA, reducing new infection rates and ultimately ending the
AIDS epidemic.
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Importance of adherence to HAART
HIV in the era of HAART. Ever since the introduction of anti-retro viral
therapy in the early 1990s, the clinical history of HIV infection and AIDS has changed
dramatically. A significant decline in the incidence of opportunistic illness and death in
HIV positive patients was associated with combination antiretroviral therapy (ART)
from 1994 through 1998 (Moore & Chaisson,1999). Around 1997, highly active
antiretroviral therapy (HAART), an improvement on the extant anti-retroviral
medication, was introduced. A study with the HIV infected beneficiaries of the United
States Department of Defense showed that with improvement in HIV treatment,
proportionally fewer patients were dying of the HIV-related illnesses (Crum et al.,
2006). In the post-HAART era (since 1997), cardiac disease, trauma, and liver disease,
as opposed to opportunistic infections seen in the earlier decade, emerged as important
causes of death in these patients on anti-retroviral therapy (Crum et al., 2006). Similar
results were reported in other countries where improved anti-retroviral therapy was
made available for HIV infected patients (Wong, Chan & Lee, 2004).
HAART produces rapid improvement in the biomarkers used to determine the
prognosis of HIV infection and progression of AIDS: CD4 cell count and circulating
Viral RNA copies (Nixon & Landay,2010; Wood et al.,2006). Greater proportions of
patients on HAART, had CD4 counts greater than 200 cells/mL at the time of their
death as compared to those in the pre-HAART era, indicating that more patients were
dying with relative immune preservation (Crum et al.,2006). Undetectable levels of
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viral RNA are frequently reported in patients who have been successfully initiated and
maintained on HAART (Nachega et al., 2007).
A high CD4 cell count means less chances of opportunistic infections and
progression to AIDS (Nixon & Landay, 2010). Patients on HAART report better quality
of life and lower frequencies of infection (Rubaihayo, Tumwesigye, Konde-Lule &
Makumbi, 2016; Nakagawa et al., 2012; Spire et al., 2002).Low volumes of circulating
viral RNA results in effective suppression of transmission of the virus from HIV
positive patients to uninfected sexual partners (Rodger, Bruun, Cambiano, Vernazza,
Strada, & Van Lunzen, 2014; Crum et al.,2006).Given the biomedical efficacy of
HAART, clinical recommendation now strongly supports early initiation of HAART
with all HIV positive patients (Günthardet al.,2016; Marrazzo et al., 2014).
Adherence and HAART. The spectacular benefits of HAART, described
above, is limited by its rigorous drug regime. Most regimes in earlier years after
introduction of HAART therapy asked patients to take multiple doses at different times
of the day, every day, although more recent regimes allow simpler (e.g. once a day)
dosing schedules (Nachega et al., 2014; Kobin, &Sheth, 2011). Adherence is a
significant determinant of viral suppression in individuals who are newly initiated to an
antiretroviral regimen (Li, Gallien, Ribaudo, Heisey, Bangsberg & Kuritzkes, 2014).
After the first month of therapy a reduction in adherence is often noted (Gross et al.,
2001). Substantial CD4 T cells gains are possible among highly adherent patients
(Gross et al., 2006; Wood et al., 2006). Moreover, the benefits of HAART therapy
decline when adherence levels fall below 90% (Bangsberg, 2006), though lower levels
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of adherence (around 80%) have been shown to produce sustained viral suppression in
many patients (Kobin, & Sheth, 2011). Incomplete adherence to HAART over time has
been found to be strongly associated with increased mortality (Gordon, Gharibian,
Chong & Chun, 2015; Kahana, Rohan, Allison,Frazier & Drotar, 2013; Lima et al.,
2001). Thus, there is an urgent need to explore and implement interventions that
promote adherence and help reap the benefits of HAART both at the level of the
individual and that of the population (Kanters et al., 2017; Günthard et al., 2016).
Barriers to Adherence. Scholars have recognized several important barriers
that affect adherence to HAART. Adherence to medication regimes in chronic illnesses,
such as hypertension and diabetes, are influenced by factors like adverse effects,
regimen complexity, perception of disease severity and psychosocial factors of
substance use and depression (Grenard et al.,2011; Phatak & Thomas III, 2006;
Osterberg & Blaschke, 2005; Kim, Han, Hill, Rose & Roary, 2003). However, the
requirement for higher levels of adherence to HAART in HIV positive patients, sets it
apart from other chronic diseases and results in additional stress and higher treatment
failure rates in PLWHA (Bangsberg et al., 2000; Boden et al., 1999).
Regimen related factors. Regimen complexity. HAART regimens are
characterized by multiple daily doses and may involve food restrictions and complex
dose scheduling (Mills et al., 2006; Chesney, Morin & Sherr, 2000). A complex
regimen and high pill burden can impede adherence (Saberi, Neilands, Vittinghoff,
Johnson, Chesney & Cohn, 2015; Altice et al., 2001; Bartlett et al., 2000). However,
some scholars have pointed out that patient’s perception of how well the regimen fitted

9

in with their daily routine better predicted adherence rather than absolute pills counts
and apparently complicated regimes (Shubber et al., 2015; Gifford et al., 2000). More
recent pharmacological advancements have enabled once, twice, or thrice daily dosing
which greatly promises to improve adherence patterns (Kobin&Sheth,2011; Nagecha et
al., 2014; Rosenbach, Allison & Nadler, 2002).
Adverse effects: One of the most frequent reasons for non-adherence to HAART
is adverse side effects (Al-Dakkak, Patel, McCann, Gadkari, Prajapati & Maiese, 2013;
Nachega et al., 2014; Saberi, Neilands, Vittinghoff, Johnson, Chesney & Cohn, 2015;).
They can be either transient like diarrhea and nausea or long-term ones of
lipodystrophy, dyslipidemia, and neuropathy (Chesney, 2003). Side effects may be
actual or perceived, but whenever reported, it is advisable to either quickly discontinue
or modify the current regimen (Morcroft et al., 2001). HAART regimens are changed
more often due to side effects rather than treatment failures (Catz et al.,2000; Monforte
et al.,2000; Morcroft et al., 2001;).
The most common side effects that cause considerable distress among patients
include fatigue, diarrhea, and stomach pain. These can usually be successfully treated
and adherence can be maintained without major changes of regimen. However,
lipodystrophy (usually manifested as fat accumulation in different parts of the body like
upper back, neck, and abdomen, with peripheral fat wasting in face legs arms and
buttocks (Carr et al.,1998; Gervasoni et al.,1999)) may be more difficult to treat
(Kasper, Arboleda & Halpern, 2000), prompting many patients to discontinue or poorly
adhere to HAART. Actively monitoring of lipid levels and insulin status together with
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other metabolic markers can help predict and prevent the onset of lipodystrophy
(Chesney, 2003). Newer agents that are not reported to cause dyslipidemia may be used
as first line of treatment to reduce chances of intractable side effects like lipodystrophy
(Haas et al., 2002).
Patient related factors. Individuals who experience symptoms of HIV/AIDS are
often more likely to be adherent despite high pill burden and complex schedules (Mills
et al., 2006; Gao, Nau, Rosenbluth, Scott & Woodward, 2000) although newer drugs
have simpler once daily schedules. Forgetting to take the pill is the most frequently
cited reason for non-adherence and individuals who regain well-being and resume their
usual routine often forget more frequently than their symptomatic counterparts
(Langebeek et al., 2014; Mills et al., 2006; Chesney at al., 2000). Lack of understanding
of the prescribed regimen along with confusion about sequence of food, water and drugs
can lead to confusion and low levels of adherence (Catz et al, 2000; Chesney et al.,
2000).
Substance use: Although habitual substance has been correlated with nonadherence (Shubber et al.,2016, Mills et al., 2006; Chesney et al, 2000a; Ostrop, Hallett
&Gill, 2000), good adherence may be achieved if provider adequately works with the
patient around concerns of safety, regimen complexity and side effects (Chesney, 2003).
Intravenous drug users may be hesitant to start HAART therapy but once started, their
adherence patterns resemble other groups (Mocroft et al. 1999).
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Depression and stress: Depressed individuals are less likely to feel motivated
for self-care and are prone to poor adherence (Shubber et al.,2016; Saberi, Neilands,
Vittinghoff, Johnson, Chesney & Cohn, 2015; Paterson et al., 2000; Murphy et al.,
2001). Social support (Langebeek et al., 2014; Shubber et al.,2015; Paterson et al.,
2000) and social stability can greatly improve adherence outcomes in all individuals
especially those that experience stress and depression.
Socioeconomic issues: Individuals living in poor socioeconomic conditions are
more likely to be non-adherent (Shubberet al., 2015; Mills et al., 2006; Spire et al.,2002;
Chesney et al., 2000b). However, it has been argued that homeless individuals and those
living on welfare in poor socioeconomic circumstances may be assumed to be less
likely to be adherent and hence not promptly offered HAART on being diagnosed HIV
positive. If providers can attempt to work with patients on issues of pill burden,
complex regimes, side effects along with challenges of poor living conditions, better
adherence results may be obtained.
Patient belief systems: Individuals who are non-adherent are more likely to
misunderstand the relationship between not taking their HAART medication, their viral
and CD4 T Cell counts and disease progression (Chesney et al., 2000a;). Confidence in
the efficacy of HAART in controlling the disease is associated with greater adherence
(Mills et al., 2006). HAART is believed to interfere with the street drug high and
conversely streets drugs are assumed to reduce HAART efficacy, leading to poor
adherence in some substance users (Ng, Rosen, Malcom, Stein & Stone, 2000).
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Patient-provider relationship: Many of the above-mentioned adherence barriers
can be effectively dealt with by supportive care providers (Ickovics& Meade, 2002).
Patients’ belief in their physician’s efficacy is shown to influence adherence to their
prescriptions (Mills et al., 2006; Siegel, Karus & Schrimshaw, 2000). Adherence can be
improved if providers and patients work through the issues of regimen inconvenience,
side effects, clarity and quality of communication and patient involvement in care
decisions (Mills et al.,2006; Chesney, 2000a).
Adherence as a dynamic behavior. Chronic diseases which require long term
adherence usually elicit complex responses from the patients. Adherence in this context
is better understood as a dynamic behavior where each of the above factors or group of
factors potentially influence each other altering the adherence in indirect and / or
reciprocal ways (Ickovics & Meade,2002). For example, complex dosing schedules may
lead to stress and the resultant failure to adhere may depress the patient which can lead
to negative belief and greater non-adherence. Disadvantaged socioeconomic situation
may limit one’s access to competent health care providers, leading to mistrust in the
available physicians and other resources resulting in poor patient-provider relationship
and low levels of adherence. Conversely, better adherence may lead to better health
outcomes which can positively influence faith in the regimen and the provider which
may further improve adherence. Hence, adherence behavior can be conceptualized as a
matrix of interrelated factors that shift over time and affect each other and the outcome
in multiple and complex ways (Mills et al., 2006; Carrieri et al., 2001; Spire et al.,
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2002). Interventions that seek to improve adherence must try to simultaneously affect
multiple locations in this matrix (Langebeek et al., 2014; Ickovics & Meade,2002).
Financial incentives to improve adherence
Financial incentives that promote desirable behavior form a part of economic
policies of most countries in the form of tax benefits and financial subsidies for
economic activities and welfare enterprises (Marteau, Ashcroft & Oliver, 2009). The
healthcare industry has witnessed a boom in the ‘pay for performance’ where providers
are incentivized over and above their usual compensation for work, to deliver high
quality, evidence based care (Volpp, Pauly, Loewenstein & Bangsberg, 2009). In view
of these programs, policy makers and healthcare scholars have wondered how financial
incentives can influence health care recipients to change seeming unhealthy behavior
and better utilize preventive health care services (Linnemayr, & Rice, 2016;
Loewenstein, Asch, &Volpp, 2013; Volpp, Pauly, Loewenstein&Bangsberg, 2009).
Insurance companies have been using incentives in the form of lower premiums and
plan benefits to encourage their clients to quit smoking, participate in exercise and other
preventive services such as screening programs (Greene, 2007). There remains some
difference in opinion regarding the just and permissible use of such incentives without
infringing on the client’s freedom and right to equal treatment. However, there have
been policy recommendations for governments in various parts of the world to include
financial incentives in their welfare spending in the form of conditional cash transfers
particularly for the underprivileged to promote what is thought as health and well-being
promoting behavior. Mexican authorities initiated the Opurtunidades in 1998, a
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conditional cash transfer scheme where families are eligible to receive cash payments
on the condition of their attending a range of preventative health care services and
sending their children to school (Fernald, Gertler & Neufeld, 2008). The children’s
fitness tax credit grants up to 500 Canadian dollars per eligible child to Canadian
parents towards enrollment of the children in physical activity programs (Leitch, Bassett
& Weil,2006). At times incentives to health service providers are coupled with
incentives to consumer-patients. For example, in Australia where the federal
government used this two-pronged approach to dramatically improve child
immunization from 56% in 1996 to 90% in 2003 (RACGP Immunization position
paper,2003). Financial incentives from governments for women to have more children,
to stimulate population growth, often with covert racial and eugenic underpinnings,
have a long history in many developed nations like France (Adler, 2003).
Specifically, for health-related behaviors, Giuffrida and Torgerson (1997) evaluated
11 published studies on the effect of financial incentives on patient adherence to
healthcare treatments. Financial incentives, they found, to be more effective than other
methods of improving adherence (Giuffrida & Torgerson,1997). For example, for
homeless people with tuberculosis, a $5 incentive proved to be more effective than peer
support (Pilote et al., 1996). Moreover, some have argued that financial incentives tend
to be more cost effective than alternative interventions, in that financial incentives can
produce better adherence at lower cost (Reiss & Bailey, 1982). Another way to imagine
cost effectiveness is to ask the question if the extra adherence achieved via an
intervention is worth the extra cost (Torgerson & Donaldson, 1994). Cost effectiveness
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of financial incentives can be argued for if substantial treatment benefits are obtained
both at the level of the patient and the society or community at large, what is known in
economics as positive externalities. A good example is the treatment and prevention of
tuberculosis. Poor patient adherence to anti-tubercular drug therapy results in more
resource intensive treatment for the individual patient later in the disease cycle and
simultaneously increases the chances of development of drug resistant strains of the
disease and continued risk of spread to uninfected individuals (Kent,1993). Financial
incentives have proven to be feasible and cost-effective in improving adherence in
tuberculosis patients (Cuneo & Snider,1989; Pilote et al., 1996). HIV infections’
treatment with HAART has similar features to that of tuberculosis regimens: prolonged
daily medical regimes, emergence of resistance due to poor compliance and the benefit
of suppressing new transmission by effective treatment of those infected. A cost benefit
analysis for financial incentives for improved adherence to HAART should consider the
positive externalities (benefit to the population, reduced cost of follow up treatment
etc.) as in the case of tuberculosis.
When non-adherence is associated with low income, as is often seen in the case of
HIV positive patients (McDonnell Holstad, Pace, De & Ura, 2006), financial incentives
might also improve equity. When controlling for other contributing factors, financial
incentives have been shown to have a greater effect among low income patients
(Sutherland, Christianson & Leatherman, 2008). The use of financial incentives in
public programs serving these groups may be a relatively inexpensive way to achieve
desirable preventive care behaviors. The dearth of studies involving long-term follow-
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up, however, means that relatively little is known regarding whether behavior changes
persist.
Looking specifically at adherence to HAART, Rigsby and colleagues (2000) found
that cue dose training (linking medication taking with individual’s daily habits) with
cash reinforcement improved adherence (as compared to those with only cue dose
training) in a predominantly African American group with history of substance use.
However, the improvements were transient and 8 weeks after the cash incentive and cue
dose training was discontinued, the adherence in the group regressed back to the
baseline levels (Rigsby et al., 2000). Thus, long term financial incentives may be
necessary to improve and sustain desirable adherence levels.
A recent multi-site study conducted by El-Sadr and colleagues (2015) found that
financial incentives did not increase overall linkage to care or viral suppression (i.e.
adherence to HAART, assuming high adherence leads to viral suppression) in HIV
positive patients. However, the study recorded significant improvement in viral
suppression in certain subsets of study sites. Hospital clinics and smaller sites which
had less than 185 patients in care showed substantial increase in viral suppression for
patients who were provided the financial incentives compared to those who were not.
Moreover, continuity to care increased in community clinics, smaller sites, and sites
with higher baseline viral suppression in the presence of financial incentives (El-Sadr et
al., 2015). These findings raise the question of why financial incentives work better in
some settings (smaller clinics, community clinics, hospital clinics) rather than the rest
and how best to implement them. An in-depth understanding of the mechanism of
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financial incentives in clinical settings for HIV can help answer some of these
questions.
The research on the use of financial incentives for care providers show their
efficacy in changing healthcare professionals’ practice (Flodgren, Eccles, Shepperd,
Scott, Parmelli & Beyer, 2011). However, the evidence from reviews that examined the
effect of financial incentives to care providers on patient level outcomes is at best
equivocal (Linnemayr & Rice, 2016; Flodgren, Eccles, Shepperd, Scott, Parmelli &
Beyer, 2011). There is a need to better understand the mechanics of how financial
incentives work in the context of HAART adherence to implement such interventions
for the future.
Conceptual understanding of Financial Incentives
The effect of financial incentives on motivation has been researched in the
classroom and workplace settings (Deci, Koestner& Ryan,1998; Frey &Jegen, 2001). A
meta-analysis of 128 experiments conducted under laboratory-like conditions found that
intrinsic motivation, as assessed by persistence in a task when rewards are stopped, was
undermined by the use of rewards (Deci, Koestner & Ryan,1998). The extent to which
these effects are evident when incentives are used to achieve health related behavior
change is unknown.
The decision whether to engage in an incentivized behavior is particularly
important when the target behavior has the potential to cause harm, as is the case with
taking certain medicines. Individuals may change their preferences or priorities over
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time and even at any given point they may have competing preferences. In the case of
adherence to antipsychotic drugs, for example, an individual may consider the side
effects of excessive weight gain and the risk of diabetes vis a vis a reduced chance of a
future psychotic episode. Providing incentives may tip the balance in favor of
adherence, however, if the full extent of adverse effects is glossed over in the context of
short term financial reward, the individual may be ill prepared for their occurrence
leading to them blaming and mistrusting the prescribing medical provider. Thus, the
question remains how incentives might be offered to facilitate and not erode informed
choice.
Finally, offering patients incentives changes the dynamics of an exchange based on
trust between patient and doctor to one in which it becomes a financial transaction
(Oliver & Brown, 2012; Heyman & Arieley, 2004). Empirical investigation is needed to
understand how, if at all, financial incentives alter the nature of patient-medical care
provider relationships.
Conclusion
The history of HIV care in the US is one that has raised critical issues of social
justice and forced engagement with vulnerable populations. It has challenged the
hitherto accepted modes of public health and medical responses to crises in that it has
mandated the system to provide speedy and increasingly widespread access to new
forms of care and health management. At the current juncture, there are
pharmacological agents which promise to improve the lives of those affected with the

19

virus and at the same time prevent its further spread. For the first time in the history of
modern medicine there is a technology that can control and effectively end an infectious
disease epidemic not by complete cure or vaccination, but through chronic management
with medicines (Deeks, Lewin, & Havlir, 2013) which requires ongoing efforts from
both the providers and consumers of the drugs. Hence, it becomes imperative for health
and human service providers to come up with modes of making this prolonged
engagement with treatment a feasible and sustainable process for all groups of affected
individuals (Marrazzo et al., 2014). While one appreciates the barriers to such chronic
management (adherence to medical regimes), it is imperative to explore and understand
the ways in which certain interventions aimed to improve adherence work with different
groups of people. Financial incentive is one such intervention which holds the promise
to improve and stimulate long term adherence (Giles, Robalino, McColl, Sniehotta&
Adams, 2014; Petry, Rash, Byrne, Ashraf & White, 2012). However, there are several
issues with financial incentives with regards to motivation, sustainability and moral
concerns regarding its potential corrupting and coercive effects on vulnerable
populations (Marteau, Ashcroft & Oliver,2009). The next chapter reviews some of these
issues and provides better context for understanding how to approach the study of such
an intervention.
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Chapter 2: Exploring the debates around Financial Incentives
Introduction
There is a substantial body of literature which has explored the effect of
financial incentives for health care providers: The Pay for Performance (P4P) programs
where providers are remunerated in accordance with their performance (Petersen,
Woodard, Urech, Daw, & Sookanan, 2006). In the recent years, policy makers have
proposed extending financial incentives to patients (a Pay for performance for Patients
(P4P4P)) as a more direct way to promote positive health behaviors like adherence to
medical advice, smoking cessation and adopting routine physical activity (Volpp, Pauly,
Loewenstein, &Bangsberg, 2009). Recent scholarship shows encouraging results with
health interventions promoting adherence and linkage to care using financial incentives
(Giles, Robalino, McColl, Sniehotta& Adams, 2014; Solomon et al., 2014; Petry, Rash,
Byrne, Ashraf & White, 2012). However, there is a gap in our understanding of how
these financial incentives can influence behavior. Although a recent work qualitatively
explores the role of incentives in adherence (Greene et al., 2017), there has been no
systematic study to understand the context specific psychosocial phenomenon that
mediates the effects of financial incentives. The major fields where such incentives
have been studied are in education, psychology, and work place economics. In an effort
to better understand the implications of what financial incentives mean for participants
in a clinical setting this chapter reviews some extant concepts and moral debates around
the concept of incentives in psychology, education and economic thought.
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Theories of Motivation
Motivational Psychology theories hold that external intervention, such as
monetary incentives or punishments, may under certain conditions reduce intrinsic
motivation to perform certain activities. In 1970, Titmuss in his influential work “The
Gift Relationship” claimed that paying blood donors will monetize the socially valued
act and will undermine the willingness to donate blood (Titmuss,1970). Thus, a
financial incentive for a hitherto voluntary act will reduce the willingness of possible
donors instead of encouraging it. Although, the thesis was not backed up by empirical
evidence, it garnered a lot of attention at the time. In 1973, Upton validated some of
these claims by demonstrating that the rate of donating blood was substantially higher
in a group of previous donors that were not offered payment to donate again compared
to those who were offered such payments for donating again (Upton,1973).
Psychologists explain this effect by claiming that under a given set of conditions,
monetary or external rewards reduce intrinsic motivation. If intrinsic motivation is
deemed beneficial, providing rewards for doing something that was previously
dependent on intrinsic motivation can prove detrimental to motivation and hence
completion of or success in the activity. This indirect negative influence has thus been
termed “the hidden cost of reward” (Lepper& Greene, 1978) or “corruption effect”
(Deci,1975).
Intrinsic motivation has been defined as the motivation one feels “to perform an
activity when one receives no apparent reward except the activity itself” (Deci,1971).
Deci, Koestner and Ryan’s Cognitive Evaluation Theory (CET) formalizes the notion of
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intrinsic motivation (Deci, Koestner & Ryan,1999). The psychological needs for
autonomy and self-determination lead to intrinsic motivation. Rewards are interpreted
variously by their recipients, and CET holds that how recipients interpret rewards with
regards to their perceived notions of self-determination and competence significantly
influence motivation. Thus “events that allow need satisfaction tend to increase
intrinsic motivation whereas those that thwart need satisfaction tend to decrease
intrinsic motivation” (Deci, Koestner & Ryan,1999). CET proposes that rewards can be
interpreted by recipients primarily as controllers of their behavior or, alternatively, as
indicators of their competence (Deci, Koestner & Ryan,1999). When rewards are
thought to control behavior, they are perceived to thwart need satisfaction. Individuals
feel that their reasons to perform a task lies outside their felt need (external locus of
causality), i.e. externally controlled by the incentive of the reward, leading to
diminished intrinsic motivation (Decharms,1968). Whereas when rewards inform
individuals of their abilities, they satisfy the need for self-competence, ultimately
boosting intrinsic motivation.
Crowding out phenomenon. Economic theory has integrated aspects of CET to
formulate theories of crowding in and crowding out of motivation. Simply put,
crowding out refers to the possibility of reducing (crowding out) of motivation or of
increasing (crowding in) motivation to perform a task with the introduction of
incentives (Frey & Jegen, 2000). As such, motivational crowding out theory goes
against the grain of traditional economic logic of increased supply with the introduction
of incentives (Frey & Jegen,2000). While much of standard economic thinking assumes
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that motivation for most economic activities comes from outside the person (economic
gain, securing economic well-being) psychology has been more interested in tracing the
locus of motivation within the person. Motivational crowding theory is an attempt to
bridge this gap.
Standard economic principal agent theory postulates that external intervention
improves performance by imposing higher marginal cost on non-performance or,
reversely increasing the marginal gain on performance (Alchian&Demsetz,1972; Fama
& Jensen,1983). This is called the relative price effect of external interventions.
Intrinsic motivation is assumed to be either absent or an exogenous constant. Cases,
where external intervention increase intrinsic motivation, the marginal benefit of
performing is higher (the crowding in effect). However, there may be situations where
the external reward reduces intrinsic motivation by making individuals feel less in
control of their actions as explained earlier. In these situations, external interventions
crowd out intrinsic motivation. Usually both the relative price effects and the crowding
out effect simultaneously occur in a situation; thus, external intervention has two
opposing effects on the performance of an individual. How the external intervention in
the form of incentives will affect the task performance depends on the relative size of
the countervailing effects of the relative price effect and the motivational crowding out
phenomenon.
Empirical evidence. Social Psychologists have gathered an impressive body of
evidence in the field of intrinsic motivation. In an authoritative meta-analysis, Deci ,
Koestner and Ryan (1998) examined studies that looked at the effect of external
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reward on intrinsic motivation. Intrinsic motivation as assessed by “the degree to which
participants return to and persist at the target activity during a free choice period
subsequent to the experimental phase” (Deci, Koestner & Ryan,1998) and by selfreported interest in the target activity. The researchers concluded that external rewards
(whether contingent on engagement with the activity, completion of the activity or
performing well at the activity) significantly undermined free-choice intrinsic
motivation. Furthermore, engagement and completion contingent rewards were also
significantly negatively correlated with self-reported interest. On the other hand,
positive feed- back tended to increase both the free choice behavior and self-reported
interest measures of intrinsic motivation. Frey and Jergen (2001) reviewed the extant
literature to find empirical support for motivational crowding out and crowding in
theory in the field of economics. They claimed that there exists strong empirical support
for such theories based “on circumstantial evidence, laboratory evidence by both
psychologists and economists, as well as field evidence by econometric studies” (Frey
&Jegen,2001).
Other researchers have found that work place financial incentives may positively
affect the quantity of performance but not the quality (Jenkins, Mitra, Gupta &
Shaw,1998; Jenkins,1986). Indeed, what Deci has simply described as intrinsic
motivation is difficult to operationalize in real life situations where there is usually a
complex web of internal and external causes for an action. Although behavior change
based on intrinsic motivation is deemed superior (Ryan & Deci,2000) and more durable
than those prompted by external reward, it is often difficult to ascertain exact genesis
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and pathways for motivation for initiating a behavior change. Neurological mapping
studies have found overlapping pathways in research participants performing simple
tasks under different motivational conditions described as intrinsic or extrinsic (Lee,
Reeve, Xue & Xiong, 2009). Qualitative work on pay for performance for providers in
primary care practice has shown financial incentives to have little detrimental effect on
the internal motivation and moral urges of primary care physicians (Mc Donald et
al.,2007).
Questions for the clinical setting
What remains to be explored is how questions of intrinsic motivation and
motivational crowding out play out in the clinical setting especially with regards to
adherence to medication. The research described earlier has been conducted mostly in
classroom and workplace settings and have been extrapolated by proponents of
financial incentives to the milieu of medical care. Adherence to medication that can
potentially sustain a healthy life cannot be simply described as a task that merely has
rewards in terms of self-fulfillment and is entirely intrinsically motivated. While being
alive and enjoying, good health is often an end in itself, individuals may have a host of
other, somewhat external reasons for staying healthy. They may want to be able to work
to provide for themselves and dependents, they may wish to be able to emotionally
support others, they may desire active engagement in communities as a way of fulfilling
civic and communal duties. All these goals can be deemed as external rewards for
engaging in the task of adherence to life saving, long term medication. Financial
rewards in these setting can be deemed as another external reward that can further
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motivate adherence. Moreover, while it is intuitive that intrinsic motivation may play an
important role in shaping behavior change especially with regards to long term medical
adherence and self-care, the exact dynamics of motivation, its sustainability and
manifestation as behavior change in the presence of financial incentives need further
explication before theoretical models can be developed. Qualitatively understanding
motivation and the external incentive’s role therein, from the perspective of the
participant is an important first step in that direction. A recently published study by
Greene and collogues was the first one to explore qualitatively the role of financial
incentives on adherence to HIV medication (Greene et al., 2017). Their results describe
some of the benefits (emotional, financial, health related) of incentives, but further work
is needed for more in-depth understanding of the issues and to develop middle range
theories which will help in implementation of incentive based programs in health care
settings.
Debates about patient autonomy. A common concern expressed with regards
to the use of financial incentives in the clinical setting, is the loss of patient autonomy
(Marteau, Ashcroft & Oliver,2009). Cognitive evaluation theory and motivational
crowding theory can be used to explain this concern. As described earlier, external
rewards can be perceived to thwart need satisfaction that comes from engaging in a
behavior for its own sake. Individuals may be led to believe that they no longer feel
empowered to do a task but do it for the sake of the reward. The locus of control moves
from within their own desires to that of the external stimulus of the reward. Patients
may perceive this loss of control as a loss of autonomy, or an inability to act as one
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truly wants to. Some professionals have long opposed payment to patients for adhering
to anti-psychotic drugs because it is thought to impair patient autonomy and attenuate
personal responsibility (Claassen, 2007). Using money to force patients to act in ways
that may be at variance with their wishes is considered paternalistic at best and coercive
at worst.
An alternate perspective emerges by considering how our actions are often not
aligned with our desires. We often fail to act in ways that in retrospect we most prefer
(Frankfurt,1988). Many individuals may prefer to eat healthier and many smokers
would rather not smoke when they think about long term consequences. However,
immediate satisfaction of desires prompt individuals to act otherwise. Thus, there is a
discrepancy between the first order desires (those individuals act on) and second order
desires (those individuals would have preferred to have acted on). External rewards may
be thought to help individuals closely align their actions (first order desires) with their
actual preference (second order desires) and thus incentives can be deemed promoting
patient’s autonomy rather than undermining it. Financial incentives are thought by
some to be a “nudge in the right direction” (Linnemayr & Rice, 2016; Thaler &
Sunstein, 2009) while others may continue to regard them as “an unacceptable shove”
(Marteau, Oliver & Ashcroft, 2008).
Analogous concepts from economic theory also help build a case for financial
incentives. It has been long maintained that people do not always think or behave in a
rational way and are often not aware of or in control of the myriad factors that influence
their behavior. Similar to the above mentioned first order desires, individuals are often
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more influenced to act to maximize immediate gains and minimize immediate losses
rather than adequately weighing long term consequences. This attitude is termed present
bias (Kamenica, 2012; O'Donoghue, & Rabin, 1999), and for behavior change
intervention it supports providing immediate rewards for targeted behavior change.
Financial incentives, can by this argument, satisfy present bias and provide instant
gratification and reinforce the desired behavior where individuals experience long term
benefits like symptom free days and good health along with the instant satisfaction of
earning the financial reward. Proponents of external rewards have asserted that
providing the “carrot” helps individuals initiate a change and enables them to
subsequently consolidate the gains and take ownership about maintaining that behavior
(Linnemayr& Rice, 2016; Dolan, Hallsworth, Halpern, King, Vlaev, 2010). It is useful
to align environments and circumstances, as with the provision of rewards, to help
people make better health choices (Klein & Karlawish, 2010). Thus, external rewards
are not inimical to patient autonomy but support it in meaningful ways as does health
education and better access to services.
Doctor patient relationship. Closely linked to the concerns about loss of
patient autonomy if financial rewards are introduced in the clinical settings, are doubts
about its possible detrimental effect on the doctor patient relationship. The relationship
between the doctor and the patient is assumed to be one of implicit trust: the patient
trusting the doctor to act in their best interest and the doctor requiring that the patients
cooperate in order to achieve the shared therapeutic goals (Pearson, & Raeke, 2000).
There lies an element of shared responsibility that transcends the financial transactions

29

between the recipient and the care-provider. Paying patients to follow their doctor’s
advice introduces a deleterious transactional aspect to this relationship. Opponents of
financial rewards claim that paying patient to do what their doctor asks them to (such as
taking the prescribed medication) tantamount to bribery and or coercion (Oliver
&Brown, 2012; Marteau, Ashcroft & Oliver, 2009). Such interventions serve to
undermine the relationship of trust and impair long term outcomes of enduring
therapeutic alliance between clients and providers.
As discussed earlier, incentives can be re-conceptualized as benign and effective
persuasion rather than bribery or coercion. If designed with the insight of the providers,
financial rewards can aid the therapeutic alliance and help the patient better align her
goals with that of the provider who is assumed to act in the patient’s best interest.
Moreover, there are several extant programs where providers are incentivized for
favorable patient outcome over and above their usual compensation. Initial research in
these settings have shown no obvious detrimental effect on the doctor patient
relationship or the moral impulses of providers in these settings (Mc Donald et
al.,2007).
It is useful to remember here that the doctor patient relationship, however
idealized, is often marked with a power imbalance and uneven information sharing.
Studies on adherence to HIV medication and other chronic medication have repeatedly
recommended an open and inclusive approach between the doctor and patient where
they share information and come up with common goals (Chesney,2003; Ickovics &
Meade,2002). Any clinical interventions (with or without financial incentives) need to
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be aware of these concerns about power imbalance and incomplete communication
between provider and client.
Financial incentives and notions of fairness, equity, and justice. Finally,
many people object to the use of financial incentives for patients on grounds of fairness.
The question being, is it fair to pay some people to do something that others do without
being paid? (Marteau, Ashcroft & Oliver,2009; Volpp, Pauly, Loewenstein &
Bangsberg, 2009). Also, is it not one’s own responsibility to ensure one’s own wellbeing? How to justify the use of public funds to ensure healthy behavior for those who
fail to take care of themselves? Public opinion in the developed western economies
usually supports the view that individuals are responsible for their own health and wellbeing and hence should personally bear the costs of self-inflicted ill health (Dolan,
Hallsworth, Halpern, King, Vlaev, 2010). However, research in causation of health and
illness especially about personal responsibility have made strong arguments for taking a
different perspective. While people do make individual choices regarding their health
(whether to smoke, what to eat, practicing safe sex, adhering to prescriptions), they are
almost always deeply influenced by the socio-economic contexts they live in (Berkman,
Kawachi & Glymour, 2014; Wikler,1987). Health outcomes are social issues
inextricably linked with questions of human rights, justice, equity, and fairness (Hudon
et al., 2016; Dworkin, 1981; Wikler,1987). If one subscribes to the view that health is a
social justice issue, financial incentives for adherence to HIV medication, especially
among under privileged groups (which consist of a disproportionate number of people
of color) can potentially balance out some of the extant structural inequalities and
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promote equity and justice. Moreover, incentive programs can be more effective to
produce desirable outcomes with disadvantaged or vulnerable populations
(Jochelson,2007).
Having said the above, whether or not public funds should be used to improve
health outcomes of a community can be answered from several angles. Firstly, it deals
with the basic question about the expectations from a welfare state and what it may or
may not do for its citizens. Neoliberal ideas support increased retraction of state
sponsored services and encourage market based insurance that signal personal
responsibility (Harvey, 2001). It is assumed that a free market will enable most citizens
to seek gainful employment and then, they can purchase health benefits through market
based insurance. The state should not encourage dependency and disincentivize gainful
employment by providing social assistance in the form of welfare benefits, cash
transfers or free or subsidized health care services. On the other end of the spectrum
socialist ideas have championed the state as the ultimate arbitrator of welfare and the
sole provider of publicly funded welfare benefits. Free for all health services, either
entirely owned and managed by the government or paid for by public money, is the
hallmark of socialist welfare states (Field & Cockerham, 2014). Most developed nations
of the West fall somewhere in this continuum (Esping-Andersen, 1990) and many like
Canada and the UK have nationalized health services while the US still relies heavily on
the private sector for health care. If there is a consensus regarding spending public
money for health care for all, financial incentives which can improve health outcomes
may find ungrudging support. In countries like the UK, which has a nationalized health
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system for the last sixty years, public opinion surveys have revealed that while most
people want individuals to take responsibility for their own health, they also see the
government’s efforts to promote health as an important part of the equation (Lynagh,
Sanson-Fisher &Bonevski,2011).
With advent of the Affordable Care Act, the US has moved towards a more
publicly funded health insurance system where the risk of ill health is pooled more
widely among the well off and historically well insured citizens along with the less
privileged, often less healthy and hitherto uninsured groups. Though recent legislation
may roll back many of the provisions of the Affordable Care Act, one may still expect a
change in the profile of people with insurance as compared to the last couple of
decades. In such a situation, financial incentives that promote healthy behavior and
potentially reduce future healthcare spending may make sound economic sense, even if
one were to disregard to social equity and human rights aspect of the problem. In case
of HIV /AIDS which has huge costs (in healthcare provision, along with loss of
productivity and hence economic output of those afflicted) an intervention which can
possibly help mitigate these costs has an intuitive appeal. More specifically the
intervention (like improved adherence to HAART with a financial incentive) not only
improves the lives of those infected with the virus but prevents the transmission of the
virus. Financial incentives for such outcomes can be seen as benefiting both the
individual who is infected along with large groups of people at risk for new HIV
infection. In this case paying the patient to remain healthy accrues huge benefits to the
patient along with the uninfected individuals.
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It is also important to remember that public funds are already being used to
derive public health benefits through anti-smoking campaigns and HIV/AIDS
awareness programs and people usually do not object to these spending. While health
education and awareness along with screening programs can potentially improve the
health outcomes for a population, financial incentives may in certain cases be a more
direct and efficient use of resources to change certain behavior.
Studies on patients’ perspectives on incentives have been few (Greene et al.,
2017). The ones that have been undertaken show that it is important how questions are
framed and usually people are more likely to support a positive reward that encourages
healthy behaviors rather than endorse punitive measures to correct unhealthy ones
(Linnemayr & Rice, 2016; Long, Helweg-Larsen, & Volpp, 2008).
Current study
Financial incentives have been understood in the context of various theories
from behavioral economics and psychology. Whether financial incentives work varies
with the population with and the conditions under which they are implemented.
Although studies have found that financial incentives may be effective in clinical
settings with issues of adherence, there has been inadequate attempts to understand and
theorize the process through which incentives works under conditions of clinical
medical care. Furthermore, financial incentives for behavior change in health and
human services raise moral questions around coercion, undermining of patient
autonomy and subversion of the ideal therapeutic relationship. However, financial
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incentives can be viewed as effective, albeit small, instruments in trying to reverse the
deleterious impacts of socio economic marginalization of certain vulnerable groups as
we try to promote healthy behavior in them. Given this context the present study
examined the phenomenon of financial incentives and its role in promoting adherence to
HAART medication in a group of resource poor people living with HIV/AIDS. The
next chapter describes the methodological approach used to study the phenomenon.
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Chapter 3: Methodology
As described in the earlier chapters, financial incentives in the context of
adherence to medication, is an understudied phenomenon. Specifically, there is a lack of
understanding of the psychosocial processes that influence patients’ reactions,
acceptance and ultimate effectiveness of financial incentives that tend to encourage
adherence to medication in chronic conditions like HIV infection. The current study
aims to fill that gap by exploring the phenomenon of financial incentives in the context
of adherence of PLWHA to HAART regimens.
Understanding adherence using Constructivist Grounded Theory
Grounded theory is a methodology that seeks to construct theory about issues of
importance in peoples’ lives (Glaser, 1978; Glaser & Strauss, 1967; Strauss & Corbin,
1998). It does this through a process of data collection that is often described as
inductive in nature (Morse, 2004), in that the researcher has no preconceived ideas to
prove or disprove. Rather, issues of importance to participants emerge from the stories
that they tell about an area of interest that they have in common with the researcher.
The researcher analyzes data by constant comparison, initially of data with data,
progressing to comparisons between their interpretations translated into codes and
categories and more data. This constant comparison of analysis to the field, grounds the
researcher’s final theorizing in the participants’ experiences.
Constructivism is a research paradigm that denies the existence of an objective
reality, “asserting instead that realities are social constructions of the mind, and that

36

there exist as many such constructions as there are individuals (although clearly many
constructions will be shared)” (Guba & Lincoln, 1994). Constructivist grounded theory
as expounded by Charmaz (2006) acknowledges constructivist limitation while striving
to create new theoretical understanding of understudied phenomenon by employing
grounded theory methods.
A constructivist grounded theory approach is most suitable for exploring areas that
have not been previously studied or theorized. It helps researchers to come up with new
and interesting insights and stimulates the creation of new, context specific middle
range theories (Oktay,2012). Hence this method is particularly helpful in cases where
there is no preexisting theory as in case of financial incentives and adherence. However,
a constructivist approach to grounded theory acknowledges that researchers are not
blank slates but come with their disciplinary foci and personal political biases. While
the focus of this method is to look at data with a fresh view keeping aside
preconceptions, constructivist grounded theory allows for sensitizing concepts to inform
the analysis (Charmaz,2006; Bowen,2006). The methodological imperative is to state
these ideas clearly and use them only in the context of gathered data. The ideas should
not be used to shoe horn the collected data into neat categories, but the researcher
should only use the sensitizing concepts as categories of analysis if sufficient data
emerges to support those ideas.
In trying to understand the role of financial incentives on adherence to medication,
I used a constructivist grounded theory approach. The sensitizing ideas of motivation,
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coercion, patient autonomy, patient provider relationship (as described in chapter 2)
were sensitizing concepts in my analysis.
Research question
Using a qualitative, constructivist grounded theory approach the present study
aimed to answer the following question:
How does the provision of financial incentives affect the process of adherence to
anti-retroviral medication in individuals with HIV infection?
Study settings
The research was conducted at Housing Works (HW), a large advocacy-based
HIV service organization based in New York City. It is intimately involved in local,
state, and national housing and HIV policy. This community-based HIV service
organization was founded in an activist tradition of HIV/AIDS advocacy. Its current
primary programming focuses on HIV related healthcare and housing programs. In
2013 Housing Works initiated the Viral Load Suppression (VLS) program with an aim
to achieve viral load suppression in more than 80 % of their HIV positive clients. It
sought to achieve this aim by promoting adherence through the provision of quarterly
financial incentives to participants who have viral loads below a certain threshold.
Additionally, the VLS program provides access to adherence support groups, improved
case management with a focus on adherence to anti-retroviral medication and services
for text reminders and directly observed therapy. Each client has the option to enroll in
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one or many of these VLS services. For example, a client may choose to attend
adherence support groups, get enrolled in the text message reminder system and if they
and their providers still feel that more intensive support is needed to help them with
adherence, they can be enrolled in directly observed therapy (DOT), where the patientclient takes either all or some of their medication under direct supervision of a nurse.
The VLS program aims to provide the client with a tool box of services that they can
employ to improve their adherence. The current study is a part of a larger study
evaluating the VLS program to identify the best practices and processes of
organizational change that the program is expected to bring.
Ethical considerations
The evaluation study of the VLS program, of which the current study is a part,
has been approved by the Institutional Review Board of the University of Pennsylvania.
Informed consent was obtained from every client at the time of enrollment in the
program. Clients consented to participate in the research evaluating the study and
signed consents forms to that effect. At the time of the qualitative interviews the nature
and purpose of the interview was explained to each participant and informed consent
was obtained verbally and then on audio recording. Participants received $20 gift cards
after each interview to compensate for their time and were issued metro cards to help
them with the transportation. These cash and transportation compensations are in
accordance with the policies of Housing Works and was provided by them from their
research funds.
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Efforts were made to protect the privacy of the participants. Upon conclusion of
this study and subsequent analyses approved by the IRB, the original recordings will be
destroyed. Names and identifying markers were removed from the transcribed
interviews and no personal identifying information (like names) was mentioned in any
report on the findings from the study.
Sampling Procedures
Participants were recruited from the list of clients who have been enrolled in the
VLS intervention program. I shortlisted possible participants in consultation with
agency personnel like case managers, program directors, medical providers, and nursing
staff. These candidates were contacted though their case managers and initial agreement
for participation was sought though the case managers. I worked with the case manager
and the participant to identify convenient time and location for the interview. The
interviews were held at the various agency locations of Housing Works across New
York City.
Sampling was continued until theoretical saturation was reached. Theoretical
saturation is defined as the point in qualitative research when new concepts stop
emerging from new interviews (Guest, Bunce, & Johnson, 2006). While other sampling
techniques target for certain fixed sample size, theoretical sampling is data driven
(Charmaz, 2006). The aim of such qualitative research is not to produce widely
generalizable findings, justified by a large or representative sample size. Instead, such
an approach explores new ideas and brings to light new and more nuanced

40

understanding of a phenomenon. Theoretical sampling requires the researcher to be
intimately involved in data collection process. The researcher needs to identify when
new concepts stop emerging and to this end must keep detailed memos of the collected
data and engage in simultaneous analysis and collection of new data. A final sample of
30 individual interviews was recruited for this study.
Inclusion and exclusion criteria: For participating in the study the clients met
the following criteria: a) be over the age of 18 and be eligible to provide informed
consent, b) be enrolled in the VLS program c) understand and speak English.
Individuals under the age of 18 and those unable to provide informed consent and not
comprehending English were excluded from the study.
Data collection
In depth interviews. The study investigator, that is I, conducted in-depth, semistructured qualitative interviews with VLS program participants. Interviews lasted
approximately an hour and were audio-recorded (refer to Appendix 1 for interview
guide). Interviews were held at a location and a time convenient to the participant,
primarily at various Housing Works offices/clinics across New York City. The
interviews were completed within a period of approximately four months from end of
May 2016 till the end of September 2016.
At the beginning of each interview, a demography /short history sheet was filled
out by the interviewer. This recorded the participant number, age, gender, preferred
pronoun, race, ethnicity along with details like date of HIV diagnosis, housing history,
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mental health history and history of incarceration (refer to appendix 2 for demography
sheet). The data thus collected helped us gain some baseline ideas about the participants
and the results are presented alongside the analysis of the interviews in the next chapter.
Simultaneous data analysis guided and shaped the data collection process and focus
of interviews. The major focus of the interviews was to explore the participant’s
experience with the VLS program, in particular how they view and are affected by the
financial incentive program in their effort to adhere to daily antiretroviral medication
regimens. An interview has been described as a directed conversation (Lofland &
Lofland, 2006). An intensive interview allows the researcher to explore “a particular
topic with a person who has had the relevant experience” (Charmaz,2006). The in-depth
nature of interviews can facilitate each participant to uniquely describe and relate their
particular experience with a phenomenon. The questions and probes provided by the
interviewer can encourage participants to reflect upon their experience and describe it in
a detailed way that is rarely possible in everyday conversations. The interviewer’s role
is to listen attentively, record observations during the interview in the way of notes and
memos, and constantly encourage the participant to respond to and elaborate on the
probes and questions that she puts to them. During an in-depth interview, the
interviewee should do most of the talking, while expert interviewers can unobtrusively
direct the interviewee to answer the relevant questions and keep them from digressing.
Having said that, digressions can often provide valuable insights to hidden processes
and hitherto unexplored concerns. The exact manner in which a particular interview
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unfolds depends on the context, the scope of the research question and the rapport
established between the interviewer and interviewee.
Grounded theory seeks to propose a fresh understanding of the phenomenon under
study. It proposes to achieve this by treating data as it is and not forcing them into prefixed categories or constructs. However, constructivist grounded theory allows the
researcher to acknowledge certain pre-conceived ideas or disciplinary focus to shape the
way questions are asked and data is analyzed. These ideas or sensitizing concepts can
guide some of the research, however they need to be substantiated by the collected data
and the data must not be forced into these categories or themes. Following this concept,
the in-depth interview looked out for certain themes or ideas that have been described in
chapter two. The interviewer sought, among other things, to elicit the participant’s view
on motivation, feelings of being coerced or bribed, relationship with service providers,
ease of integration into lifestyle with respect to adherence and the financial incentives
of the VLS project. The interviews were audio recorded and then transcribed by me
during the period of data collection. These transcripts became the primary data for the
results presented in this study.
Focus groups. In addition to the individual in depth interviews, I conducted one
focus group with seven VLS participants. The focus group lasted for one and half hours
and was audio-recorded, and then transcribed. They were moderated by me and one
other researcher from the IRB approved research team. The focus group was conducted
before the data collection through in-depth interviews began, as preliminary ground
work to gain a sense of the general issues that the participants were concerned with.
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They aimed to elicit the participants’ views on adherence, challenges to adherence and
the processes in which participating in VLS program is affecting those issues. The data
from the focus group helped me design the interview guide for the study. Focus groups
can serve to elicit different aspects of the process that individual interviews fail to
reveal (Stewart & Shamdasani, 2014). They are especially useful in obtaining group
level opinions and perceptions of phenomenon (Charmaz & Belgrave, 2002). In the
context of a community based service provider organization like Housing Works, focus
groups can be especially expedient in exploring community level processes and
opinions that affect participation in and outcomes of an invention.
Field notes. Fieldnotes document information, impressions and relevant cues for
the researcher (Corbin & Strauss, 1990). These hand-written notes recorded the
impressions, incidents and feeling during the process of interviews, focus groups and
other interactions in the agency settings. Field notes captured what the recorded
interviews did not, for example, if the participant was showing the interviewer some
object, or how the interviewer gauged the mood of the participant as they were
discussing an issue. Field notes were analyzed alongside the interview transcripts as
primary data.
Qualitative Data Analysis
I transcribed the in-depth interviews and focus groups. The online software
Dedoose was used in coding and analyzing the data (Version Dedoose,2013). As
mentioned earlier, data collection and data analysis was a simultaneous process. I
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looked at the initial 10 interviews and the codes and themes arising from this analysis
was subsequently used to direct the later interviews. The new interviews thus collected
contributed to further analysis and refinement of conceptual categories. Through this
constant interaction between data analysis and data collection, theoretical abstractions
true to the collected data emerged (Charmaz, 2006).
Constructivist ground theory was used in the qualitative data collection and
analysis. Charmaz’s (2006) conceptualization of grounded theory emphasizes the role
of interpretation and meaning and the notion that meaning is co-constructed by the
researchers and the interviewer and is not simply “discovered”. Specifically, she
highlights that grounded theory is an interactive and interpretative process, in which the
researcher is conceptualizing and constructing the participants (re)construction of
reality (Charmaz, 2006). Researchers are not objective observers; rather they are a
valuable part of the research and interview process and outcome (Guba & Lincoln,
1994). Unlike the initial conceptualization of Glaser and Strauss, Charmaz specifically
argues that “…neither data nor theories are discovered. Rather, we are part of the world
we study and the data we collect. We construct out grounded theories through our past
and present involvements and interactions with people, perspectives, and research
practices” (Charmaz, 2006). In addition, grounded theory should not be utilized as a
formula to collect and analyze data, but rather an emergent method. A constructivist
grounded theory methodology was used in this project as I was interested in exploring
how financial incentives influence or make an impact of patient’s decision to adhere to
medication and their life choices around these decisions. The constructivist caveat
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signals that ideas reviewed from existing literature, like motivation, provider patient
relationship, regimen complexity had some influence on how I made sense of the
emerging data. However, the objective was to move beyond these ideas and evolve new
theory to facilitate a better understanding of the phenomenon.
First, I read the transcripts, without coding the data which was followed by initial
coding. Coding is the process of categorizing and naming segments of data (Charmaz,
2006). Initial coding helps the researcher to be grounded in the data. This involves
either a line by line or incident by incident coding of the data. Subsequently these initial
codes were compared between the different interviews. This comparative exercise
helped clarify new codes or categories and ultimately lead to the emergence of themes
and patterns (Charmaz, 2006). Through this process of comparison and refinement,
initial codes evolved into focused codes. Diagrams and notes were used to form
conceptual audit trails (Charmaz, 2006). Specific attention was paid to the phrases or
words participants have used in the interviews (the next chapter will detail some of
those, also refer to appendix 3: notes from research journal). Charmaz describes these
phrases to be in vivo codes in that they are the “symbolic marker of the participant’s
speech and meanings” (Charmaz, 2006). These in vivo codes help the researcher to stay
grounded in the actual data and away from preconceived concepts, by using the
participant’s actual terminology to develop categories. Proceeding from focused codes,
categories were developed from the data by clumping focused codes together. In the
final level of analysis, theoretical coding was used to establish connections between the
categories developed from the initial coding. Conceptual diagrams were created and
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refined through this process (Figure 1 in chapter 4 on page 45). Throughout this analytic
process memo writing helped organize ideas and expedite the process of transitioning
from initial codes, to focused ones, therefrom to categories and finally to abstract
theoretical constructs. Excerpts from the research journal is available in Appendix 3 ,
where examples of the process of transition from primary to focused and then to
theoretical coding is documented.
Establishing Rigor. Establishing rigor is an important component of grounded
theory that helps to ensure quality (Padgett, 2008). A few strategies were employed to
enhance research rigor. First, research decisions were methodologically transparent
(Charmaz, 2006; Oktay,2012). All details regarding coding and category development
was noted. I maintained a researcher journal for the purpose of writing every step in the
research problem and noted any concerns like logistics, ethical issues and theoretical
problems during the process of data collection and analysis. This process of maintaining
an “audit trail” (Padgett, 2008) helped map the course of developing concepts and
themes and strove to clarify all the interim steps between data collection and final
theoretical conclusions (refer to appendix 3).
Member checking were planned to provide participants with the opportunity to
comment and contribute to the findings (Creswell, 2007; Padgett ,2008). However, due
to logistical challenges, at the time of writing this report we had not been able to
conduct any member checks. We plan to do them in the near future in consultation with
the agency. Triangulation of the data using interviews with the field notes and focus
groups was undertaken to ensure validity of the findings (Oktay, 2012). Furthermore,
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throughout the process of data collection and analysis, I discussed the process with my
advisors and research peers. This form of peer debriefing (Padgett,2008) helped clarify
ideas and ensure that the analysis remains true to the data obtained.
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Chapter 4: Results
Introduction
The financial incentive along with the other supportive services reinforced, for
some participants the motivation for better adherence to medication and improved their
attempts to ensure their health. Some participants felt, more than ever before, supported
in their medication adherence issues and they sought to optimize these resources to seek
better outcomes for themselves. Psychologists working on financial incentives have
theorized that external rewards may undermine intrinsic motivation of participants to
engage in an activity (Deci, Koestner & Ryan,1999). Such an undesirable reliance on
these external stimuli results in less motivated participants and their output/outcome
may ultimate suffer in the context of these incentives. However, proponents of
financial incentives point out that external rewards may sometime help individuals to
better align their immediate actions to longer term goals (Marteau, Ashcroft & Oliver,
2009). External rewards may help participants to perform the difficult task at hand
which can yield beneficial long term results. A qualitative study of the Viral Load
Suppression (VLS) financial incentive scheme with the clients found support for the
latter view. In this chapter, the results of the study in the context of a model for
motivation through financial incentives that was developed from the research findings
are presented.
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Participant Characteristics
Our participants were drawn from the list of clients provided by housing works
and were contacted through their case managers. Table 1 below summaries the
demographic profiles of the participants. Out of a total of 30 participants, 17 identified
as women, 10 identified as men and 3 identified as transgender women. Their ages
ranged from 35 to 75 years with mean age of 50.9 years. African Americans comprised
40% (12), Blacks made up 36.6% (11), Hispanics accounted for 3.33% (1), Latinos
made up 10% (3), Mixed race comprised 3.33% (1), and Whites made up 6.66% (2) of
the study sample.73.33% (22) of the participants had a history of substance use, and
40 % (8) reported a mental illness history. About 63.33% (16) reported a history of
incarceration. The number of years since HIV diagnosis ranged from 9 months to 22
years with a mean of about 8.6 years. Apart from one man who reported independent
income, the rest reported being reliant on welfare benefits, though we did not ask the
details of income and the different benefits that they accessed.
Table 1
Participant Characteristics
N=30

Gender
Woman
Man
Transgender Woman

(%)

17

56.67%

10

33.33%

03

10%
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Age
35-45
46-55
56-75

11
09
10

36.67%
30%
33.33%

11
12
02
01
03
01

36.67%
40%
6.67%
3.33%
10%
3.33%

16
09
04
01

53.33%
30%
13.33%
3.33%

12
09
08
01

40%
30%
26.67%
3.33%

19
11

63.33%
36.67%

22
08

73.33%
26.67%

Race
Black
African American
White
Hispanic
Latino
Mixed

Sexual Orientation
Heterosexual/Straight
Homosexual/Gay
Bisexual
Other
Years since HIV diagnosis
0-5
6-10
11-20
>20
History of Incarceration
Yes
No
History of Substance Use
Yes
No
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History of Mental Illness
Yes
No

12
18

40%
60%

A Theory of the Effect of Financial Incentives on Adherence
The aim of this study was to develop a middle range theory employing a
grounded theory approach, to understand the role of financial incentives on adherence
to HAART medications in HIV positive people enrolled in an adherence intervention
program (The Viral Load Suppression program or VLS) at Housing Works. We found
that financial incentives shaped adherence to HAART by influencing motivation to
adhere to the medication, as well as the barriers and facilitators to adherence present in
the individuals and their environment (Figure 1).
Motivation has been the major focus of research on incentives, however the
components or processes through which motivation works especially in a clinical
setting has not been well theorized. These results suggest that there were symbolic and
material aspects to the effects of financial incentives on motivation. Facilitators of and
barriers to adherence were both influenced by financial incentives and the facilitating
factors in turn influenced the effect of the incentives. That being said, not all barriers or
facilitators were equally influenced by incentives. The factor of motivation was also
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Figure 1. Proposed model for the Effect of Financial Incentives on Adherence
to HAART.
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heavily influenced by the facilitators and barriers to adherence and motivation itself , in
turn, had some effects on the effect of the facilitators and the barriers . Figure 1 depicts
the proposed model. This is an initial suggestive model where the arrows indicate
possible connections and directions of influence. The extent of these connections and
interactions are described qualitatively in this chapter.
Motivation
The payment of incentives for adhering to health promoting behaviors sent out
complex messages. While it has been argued that the payment of incentives can be
thought of as coercion and bribery, our participants differed with that view. The
incentives motivated them, beyond the usual practice of adherence counseling and
support, to adhere to the recommended HIV medication. They felt motivated to enroll in
the program and take better care of themselves.
This study proposes that the motivation comprised of two distinct but
interrelated processes, one of symbolic meaning derived from the reward and the other
being the actual material benefits obtained from the cash incentive. Furthermore, under
symbolic meaning we identify four, separate yet overlapping, processes: deriving
meanings of self-worth, stimulation to self-care, orientation towards community care
and imagining possible futures.
Symbolic Motivation: Self-worth. The VLS program, with the Incentive and
other special adherence focused services, was generally well received by most
participants. For some clients, the implementation of these new and improved services
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(directly observed therapy, adherence groups, and text message reminders) along with
the provision of financial incentives signaled that the providers were concerned about
their adherence and general well-being issues. The concern on the part of the providers
were interpreted, by some, to mean that they, the clients, were worthy of that concern.
This in turn translated to a greater sense of self-worth among some participant clients.
One client mentioned how this program was a response to her own felt need and
how it has served that need.
I was horrible with my medication, always horrible. Then I thought that’s why
they have this program because I am not the only one. This program gives me all
the things I need. I am thinking about my medicines more, I am less likely to forget
about them these days. I have doctors and nurses talking to me about it. My case
worker checks in with me about my meds. I get regular blood works and know my
results, my CD4 s. I am working with this program to become undetectable. In the
end the incentive comes along and that feels good. (Black woman, 54 years)
She admits that in the past she had trouble with taking the medication regularly. The
intervention, according to her, has responded to that need. She described how the
program helped her focus on her adherence with all the major care provider groups
talking about the issue. Her being enrolled in the program, which requires regular clinic
visits and quarterly blood examinations, provides her feedback on her efforts at
adherence. She feels a sense of partnership with the service providers in their common
cause of her adherence and well-being. The incentive provides an additional reward
over and above the services and attention, which overall, she regards as a satisfying
experience.
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Another Black woman echoes the sentiments expressed by the earlier participant.
She describes her views on the incentive in the following manner:
A 100 dollars to save your life? That’s a no brainer. It gives you great incentive to
take your medication. It is like getting rewarded for doing the right thing. It is
great, I feel very happy to be in this program. I think I am special and I deserve the
care and the love of all these people. I will not let them down. I tell myself that you
deserve to be healthy and now you can be healthy and live your life. (Black
woman, 55 years)
We see how for this participant being a part of the intervention has improved her sense
of self efficacy towards her adherence behavior. She clearly mentions how she feels that
she deserves to be a part of the program, how she feels worthy of their care and how it
prompts her to do her own part and feel more confident of her abilities to take care of
her own health. Self-esteem or self-worth in this case is influencing self-efficacy.
Though we cannot claim any causal links between the two from this study, it is certainly
worth noting the association for future research.
The most succinct remark about how this intervention in general and the
financial incentives in particular, has affected-self-worth perceptions came from a 55year-old African American man. When asked to describe how he feels being a part of
the VLS program he said, “I feel like a White Mama.” He went on to explain that for
the first time in his life he feels truly cared for. Not only does he have access to
improved services but that ‘someone’ cares enough to reward him with 100 dollars for
staying healthy. The reward money indexes a sense of worth. The actual amount was
not perceived as a mere monetization of that worth but signaled a commitment on part
of the providers to care for the health and well-being of the participants, who are
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economically underprivileged, socially devalued citizens. It is interesting how this
new-found self-worth experienced by this African American man finds expression in
his identifying himself with the privileged, racial other (“the white mama”). While we
cannot ignore the irony of the statement, we can cautiously argue that this program
helps this participant feel like a worthy consumer of quality care (something that the
more socioeconomically privileged have regular access to) rather than a stigmatized
welfare recipient.

Symbolic Motivation: Self-care. Self-care encompasses those activities like
healthy eating, physical exercise, and self-regulation of substance use, emotional selfhelp exercises and alternative therapy which contributes to better health outcomes.
These activities are often self- initiated and may be under the individual’s control and
seek to regulate the self with an aim of gaining a certain desirable health outcome. Selfcare has been conceptualized as the other end of the spectrum from healthcare provided
by trained medical providers (Chambers, Wakley & Blenkinsopp, 2006). The urge to
self-care is perceived as an important factor in ensuring desirable health outcome and in
chronic conditions like diabetes, hypertension, and long term HIV infection. Self-care in
cases of chronic illness is correlated with positive outcomes (Segall & Goldstein,1989)
and is a necessary adjunct to care accessed through the professionals. Chronic diseases
need life style modifications and regular adherence to medical advice. Self-care for
choric diseases can be viewed as adopting the medical advice and adapting them to
one’s needs and daily routine.
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The participants in the study described the urge for self-care. They identified selfcare as an important way to ensure their longevity.
It was devastating and really to this day it still is when I see certain commercials or
people talk about it in the street it makes me feel fucked up in a sense, you know
but then at the same time, I be like everything happens for a reason, that’s how I
look at it. I do not let it get me down, I do not let it, you know, get me depressed
where I feel awful, my life is over because, you know, because being now with all
the information they got on it now, you know, how it was back then, then they did
not have certain medication and certain things so being now like everything is
different now, I feel much more, much better about it. I know I can live longer and
healthier, you know depending on how I take care of myself. (Black man, 38 years)
The participant went on to describe how adhering to the medication is now an essential
part of his self-care routine:
I wake up, brush my teeth, make myself breakfast and like clockwork, open the
bottle of meds. I do not miss a single day. I have done that before. I would not
bother. I know now, I know that I can’t miss a day. Your levels shoot right back.
All this work goes to waste. I tell others too, take care of yourself, like you brush
your teeth so that your breath don’t stink, take those pills so that you do not rot
inside.
Incorporating the act of taking the medicines into one’s daily activity is an important
way to remember to take them (Rigsby et al.,2000). Comparing taking of the medication
with that of brushing teeth to maintain oral hygiene points to how participants have
adapted adherence to their quotidian routines. Every single day individuals take care of
their bodily needs and maintains physical hygiene with an aim to preserve one’s self
(“do not rot inside”) and be socially presentable (“breadth don’t stink”). Self-care thus
comprises of these small, routine activities which one may carry on without intense
deliberation on a day to day basis.
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The VLS intervention and the financial incentives in particular, have influenced
many a participant’s urge to self-care. A 45-year-old, African American woman
describes how she now feels the need to take care of herself more than she did in the
past:
I must take the meds, I have to do it better now. I would forget before, but now
umm mmm. I can’t do that anymore. I need to be on point, my doctor is on point
my case manager is on point. I need to be on point. I work hard and try to support
myself and stay healthy. I need to take care of myself, you know, if I do not do that
I do not have good CD4, I am not undetectable and I do not get my card. Now we
can’t let that happen (laughs). Now do not get me wrong, I would take my
medicines anyway, but now you know it is like everyone will get upset if I do not
take my medicines. It is my incentive to take the medicines.
The perception of increased self-worth, as described in the previous section, prompted
some of the participants to take greater care of themselves through acts such as routine
adherence. The incentive directly stimulates this self-care and adherence behavior by
rewarding such behavior at regular intervals.
It is good incentive to know that your health is worth something, you get rewarded
for doing a good job with your health. It is like getting the employee of the month,
get rewarded for doing a good job with your health. (Mixed man, 47 years)
The money is a reward for a “job well done” and inspires one to engage more broadly
with healthy living. A 60-year-old African American woman claimed:
The undetectables program is great because it gets you talking about your health,
taking your medicines, eating properly, resting, and taking care of your health.
Besides it gives you 100 dollars every four months. I like it because I am
undetectable, because I got to do everything in my power to remain undetectable.
She identified taking care of her health as an empowering activity, something that may
in itself lead to increased sense of self-worth. For her the incentive is an encouragement
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but not a necessary pre-condition for adherence. She says, “Gift card is nice, but my
health is more important than a gift card.” This participant reflects a pattern where one
acknowledges the role of the financial incentives in motivating better adherence
behavior, while at the same time claim that the incentive is not the only reason they stay
adherent. An analysis of social desirability underpinning such responses can be useful.
Another participant claims that being a part of the program has prompted him on a
path of self-love and self-care, with financial incentives helping him stay the course.
I guess I love myself more now. I want to continue to love myself and look after
my health. I check in with myself every day and I tell myself you need to take care.
You don’t miss a dose. Please take care and love yourself. Who else will? And I
have 100 dollars every three months to spend on myself for taking care of me.
(Black man, 42 years)
For a few participants, self-care and general adherence was directly linked with a
desire to maintain a certain kind of “look”. A 35-year-old Black woman confided, “I am
vain so I want to look good. You need to take care to look young. I do not want to look
all dead and sick.” She further explained that she does not want to prioritize looks over
health, but considers good health sometimes makes one look “good and young”.
Another participant opined that one’s appearance was inextricably linked to one’s
health status.
We were told that you can’t tell if a person has HIV by looking. Yes, when you are
young and first catch the virus, you can’t tell. But now as we get old, our bodies tell
on us. I can look and tell. She has the virus and no she does not take care of herself.
I can tell. You end up looking all hollow, your bones show. (Black woman, 42
years)
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She concludes that by remaining adherent you can “fool” people into thinking that you
do not have the disease.
Look at me, I have been undetectable for so long now. I don’t look old like some of
my friends. They tell me that they are envious. They say XXX you are gorgeous.
Your skin is flawless. I say I want to look this way all the time so I take my pills.
My new boyfriend can’t believe that I have been sick for so long. I told him, I got
you fooled too. Like my friends, he says I am faking it.
In her case the routine of self-care was invested with meanings of beauty and personal
pride. Conceiving of health as a state of looking good and feeling good can help patients
better relate to the idea. Some patients may find it easier to work towards the personal
and subjective goals of looking and feeling better rather than the so called objective
biomedical outcomes of blood reports and other bio-clinical parameters.
Continuing the theme of physical appearance and adherence, a third participant
pointed out how being undetectable and taking care of one’s self was essential for
elective gender reassignment surgeries.
For transgender women if you have to get like cosmetic surgery for the breast or
bottom surgery, you have to be undetectable. That is for any surgery, you have to
be in tiptop shape before they cut you. Like Diabetes it takes us longer to heal.
(Black transgender woman, 37 years)
Thus, for some participants, looking a particular way whether by maintaining good
health or remaining healthy enough to undergo surgery to look a particular way could
be attained through routines of self-care. Adherence to HAART was the corner stone for
such routines of self-care and self-preservation.
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Symbolic Motivation: Future orientations. Chronic diseases alter the way
people imagine and plan for the future (Bury,1991). For PLWHA (and for the rest of us)
the future represents a hazardous state of the unknown. If people believe that they have
some control over the events in the future then they are more likely to plan and act on
certain measures that ensure a future that agrees with their life goals. In case of chronic
diseases, the perceptions of the prognosis of the disease, i.e. how the disease is going to
play out in the future, influences how people can plan to take control of their lives. In
the case of HIV infection, the knowledge that it can be a condition one can live with
helps some people come to terms with its otherwise life altering effects. Planning to
adhere to the medications for HIV can form a salient part of how a person plans and
prepares for the future.
The participants in the study provided several examples of how staying adherent is
now a part of their future planning.
I want to do this for myself. I want to live a long and happy life. I tell people that if
I do not do something now how can I live for the next ten, twenty years. I
contracted this disease when I was in my teens, now I am in my thirties, I have
survived this long, I don’t know how, it was God’s grace. Now I have these
medicines and I can take them every day and get by and get work done. I can feel a
change, I can feel that I will live and remain healthy. (Black transgender woman,
37 years)
This participant is clearly hopeful about the future. The fact of her surviving ‘this long’
instills that sense of hope, she perceives it as a blessing. However, she recognizes the
opportunity of good health as promised by the medicines and actively plans for her long
and healthy life by remaining adherent. Another participant concurred with her, when
she described how she plans her future life and health with the help of these medicines.
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I got this when I was 26. I think I was already old then, the kids these days live out
their lives in a flash, they are gone before you notice them. I think of the future, I
want a job and my own place. I need to live out my dream, I have to live for my
dream. I have to keep my health to enjoy the life I want, I can’t be dying every day
and trying to make by. I need a complete life. I need these meds to work for me.
(Hispanic woman, 43 years)
This participant associates good adherence behavior with her desired long life and
thinks that she can work at her job and generally make a success of her life if she stays
on the path of adherence. She also notes how she does not desire merely to survive
(‘trying to make by’) but thrive on her goals and dreams. Adherence thus becomes a
part of that desire to thrive and can also be perceived as the essential gateway towards
that complete and healthy future. We have mentioned how adherence has become the
gateway, for some, to greater self-care and general healthy living. Here we propose that
a plan for the future and imagining adherence as an essential gateway to that future can
influence participants’ involvement and motivation in maintaining their health.
For some participants, being a part of their family’s future was a great motivation
to remain adherent. Women especially described how they expect that by taking the
medicines and staying healthy they can ensure a better future for their children.
I want to see my grandchildren, so you know that will take a long time (laughs). I
take the medicines every day, eat right and plan my life. I think I should be around
a long time to see them grow. My daughter wants to go to college. I want to be
there for her. I want this to be a happy life for us and see her successful. (African
American woman, 38 years)
A-75-year-old, African American man shared how he was motivated to stay adherent by
his desire to continue to be the grandfather that his young grandchildren can come to for
affection and advice.
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My son lives in Philadelphia, he has two boys. They come down and visit me, I go
there once a month, sometimes twice. The grandchildren love me. I take them out,
you know that place by the river and then they want ice-cream and go to the
movies. I love movies, love animation. I watch Family Guy, they cannot watch it
(laughs). I watch the Tarzan movie with them. They love me, they tell me their
secrets (laughs) something they can’t tell their Mama. They ask me what can I do
Granddad if I get into trouble. I am an old man so I can help them, have fun with
them and teach them from my experience. I have to stay alive for that, if granddad
is gone who will take them to the movies? They also ask me you taking the
medicines, you taking care Sir? I have to, you know what I mean, I want to see
them become men and have children.
Another older Latina woman when asked how she remembers to take her medications
everyday said:
While I am taking the meds I imagine my grandchild’s face, I am fifty seven and
have eleven grandchildren. I imagine them growing up. Yes, I want to be healthy, I
want to be there. It is a gift from God- my life, all that has happened to me, now I
have to do my part. (Latina woman, 57 years)

While wishing to enjoy of one’s own future and that of the loved ones’ by
imagining a healthy and long life sustained by rituals of self-care can promote
adherence, the fear of a ravaged and miserable future-self prompted some participants
to focus on self-care. Almost all participants had known a person who had died of
HIV/AIDS or have suffered severe ill health and disability due to the infection.
Observing, from close quarters, what an unmanaged disease could do to a person
provided a cautionary tale for some of the participants. In their turn, they resolved to be
adherent and take good care of themselves in order to escape similarly painful future
states.
I have seen how my friend died. He stopped taking his meds and never stopped
drinking and he dies a slow and miserable death. I see that and get worried. I can’t
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be like that, umm no. I love myself too much to see that happen to me. I wake up
and take my meds and start the day. (Black man, 36 years)
Similarly, another woman describes how she is afraid to look and feel like those who
are dying from the disease. She is horrified at the thought of the decay and decrepitude
brought in by unmanaged HIV infection and she resolves to eschew that future by
remaining adherent and healthy.
I see these people walking around (those who have been non adherent), they are
rotting from inside, like a fruit that has been out for too long, sorry I am vain but I
do not want to look like that. I do not want to end up a walking zombie, a rotten
fruit with dry skin over my bones. I must start now not to get that way ever. (Black,
transgender woman, 37 years)

The way a participant saw the future influenced what they felt they could or should
do in the present. In case of fatalism, individuals believe that the future is a predetermined inevitable which is unaltered by any amount of present individual will or
action. Such a belief in PLWHA, can lead in some, to complete hopelessness and make
them willfully ignore advice surrounding HIV medication and other health promoting
guidelines.
I thought I was going to die, so I did not care about meds, doctor visits, reports. I
was seeing everyone around me die. In one week, I received news that three of my
friends in Detroit had died. I told myself, it is my turn next. They had done nothing
to deserve this, I have done nothing to bring this on me. Sometimes you accept it as
God’s will. I felt I should just have fun. I went out and got high and I was a mess. I
did not care where the next one was coming from, I could not get infected again.
My mother called up and cried, she asked me to stop drinking and I was like I want
to die happy and drunk, not sad and clean (laughs). (Black woman, 50 years)
Hopelessness about the long-term future can cause people to lose the will to live and
subsequently they give up on any actions (like adherence and other health advice) that
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may influence future health. Fatalism and the attendant hopelessness can result in
reduced self-efficacy in trying to adhere to medications and other desirable health
promoting behaviors in the belief that they are ultimately ineffective in halting the
disease and delaying death. Hence, while imagining and planning for futures can have
motivate people to adhere, a fatalistic outlook with an presumed unmanageable future
can encourage unhealthy practices which lead to instantaneous gratification like
uncontrolled, hazardous substance use as described in the earlier quote.
Breaking this link of fatalism is a challenge for care counselors and service
providers, making patients claim agency in their future and hence present lives is an
essential first step towards aligning the goals of the patient with that of the provider
towards sustained adherence. When the future is perceived as a site of hope and
promise, individuals can adopt more positive and pro-active attitudes towards the things
that they can do now, in the present moment such as adhere to medication regimes.
Now these medicines make you live long, I have messed up my life before, but now
I want to live a happy life. If I do not take the meds I will die, I need the meds to
keep me alive and I need to be alive to do all the things that I have planned for
myself. (Mixed man, 47 years)

Financial incentives can be imagined as one of the ways to link up present action to
future goals. The literature on rewards and incentives claim that contrary to claims of
the rational choice theory, individuals often act in ways that are ultimately harmful for
their gains or well-being. Moreover, humans have a bias for selecting short term
rewards, or immediate gratification over distant, long term benefits. Providing a short-
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term reward like a financial incentive for a behavior which has a long-term salutatory
effect may be a way to align the need of immediate gratification with long term goals.
Participants in this study mentioned how the money helps them out both in the short
term and keeps them on track for a healthy future.
The money comes in handy, you know what I mean. 180 dollars every two weeks is
tight (referring to welfare benefits). I work towards getting that gift card, yes ‘cause
the 100 bucks is sweet but I am also taking the meds and making sure I live long
and happy. It is a win-win, why change a thing. (African American woman, 60
years)
A 45-year-old white woman observes how for some people she knows in the program
the money is helping them do the right thing for the future.
I do it for myself, for keeping healthy. I know of some who do it for the money, I
am not sure if they would have done it otherwise. They want the card and hence
they get to know their viral loads and stay on their meds. But I see how their health
is much better, they say I want the money but I see them getting better and eating
more, staying on point and now they will be around for much longer, they will
outlive me (laughs) and I am already so healthy.

Instilling such a “future orientation” may be one of the most important goals for a
therapeutic relationship that desires sustained adherence. We will discuss the
implications of such an approach in greater detail in the next chapter.
Symbolic Motivation: Community orientation: Adherence has always been
conceptualized as an individual level behavior. However, like most behaviors it is
affected by what others think of that behavior, what Theory of planned behavior has
called community norms (Ajzen,1991). Community norms are the most difficult to
change, and some behavior change scientists have identified these norms to be some of
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the strongest factors for bringing about behavior change (Fishbein & Guinan, 1996). In
this study, some participants described the community norms as they were prevalent
before the program and then they noted how some aspects of those norms have
changed.
I have had this virus for twenty years now. Many of my friends have HIV, some
have died, some survived. We never used to talk about this before. We were too
scared. When we started the medication, we kept it to ourselves. I was like just take
it and forget about it. Only once a year my doctor would ask me, are you taking the
pills? I used to take them and sometimes I forgot. No one was holding me
responsible, asking me about the pills. (Black woman, 50 years)
Another woman described how things were before she started the VLS program:
Too many things to worry about. I was homeless and did not like the SRO room I
was allotted, I was focused on getting out. My case worker was helping me with
that. I have too much trouble in my life. The medicines would be there in my bag, I
used to forget, not because I did not want to take them, but it was not like this when
I was being reminded by everyone to take the meds all the time. I did not talk about
my disease or my medication with anyone. (African American woman, 56 years)
The program has changed some of the silence around medication. While the participants
still described the various stressors in their lives (refer to the later section on
“Barriers”), they noted that they had become more mindful of their medical condition
and the need to take their medication every day.
The kind of person I am, I take my pills every day. My Doctor is happy with me,
she tells me that my blood tests are great. I never have been detectable while on the
program. Earlier I may have forgotten a few doses now and then. I was not sure if
that mattered too much, but my levels would shoot up. I did not want to be
bothered. I wanted to look for work and be on my own. My health was never very
bad, but now I know if I do not take care and take my pills every day I can become
very sick. I have seen people go like that. I now tell everyone please take your pills,
you want to live, right? My case worker, god bless her, she is wonderful and she is
always on my case (laughs) tells me XXXX you are taking your pills alright?
Please remain healthy. If I do not take care of my body how will I work? The gift
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card (referring to the incentive) helps me along, I have it in my wallet as a constant
reminder. I am always aware of my health these days. (Black man, 42 years)
The increased awareness about the importance of adherence among the study
participants can be partially linked to the more focused conversations that they are
having with the service providers about remaining undetectable. The incentive acts as a
nudge in directing behavior in some and further focus the conversation around health
and adherence.
Being in an environment where everyone was talking about and taking their pills
helped many to model their behavior after their peers. The support and the caring
environment coupled with the repeated messages from the provider along with the
stimulus of the financial incentive made a few participants adhere to their HIV and
other medical regimens. A 62-year-old African American woman, resident at one of the
transitional housing programs at Housing works, described her before and after story in
the following manner.
When I was in North Carolina, I was depressed. I was not ill, I could go to work
and live a normal life. But I knew that I will die soon, I went to the doctor and he
gave me meds for the depression. I took them for some time and then stopped. I
was sure nothing will help.
Then she describes her experience with Housing works and the VLS program:
When I moved here, I saw everyone like me living here and Miss A was so helpful.
I loved it here. Then I got tested and my viral load was 1000 and so she said get on
the program and you can earn money. I am now undetectable. I would never want
to take the medicines before, I was depressed and lonely. Now I take HIV
medicines and my depressions medicines every day. You see everyone around you
take their medicines and you feel like taking them. You get rewarded for it at the
end.
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Social support found within the community and at times within the family and romantic
relationships encouraged some people to enroll for the VLS program.
My partner was in this program, and she told me to join. She asked me to contact
my case worker and see if I was eligible. We live together, so when we join our
incentives we can use that for our expenses. Now we are asking each other, please
take the meds, we need to remain undetectable and get that card at the end of the
month. We help each other with remembering. I am so happy that my wife got me
into this. (Black man, 36 years)
The participant in the above-mentioned quote went on to describe how his wife
continues to talk about the program, how she is proud to be a part of the intervention
and has taken up the duty of spreading the word about staying adherent in her social and
family circles. Although, the financial incentive was cited as an initial motivation to
join the program, he recognized how they have gone beyond “just that thing” now that
they have been adherent for over six months.
Many participants reported that they were talking about the program with other
clients of Housing Works and their friends who were not with Housing Works, with an
aim to encourage them to join the VLS-Undetectables program. The incentive aspects
featured regularly in such conversations.
I told her, why don’t you join the undetectables program. You get the reward, you
know, one hundred dollars. You will get good care. It is a win-win situation. I tell
people, there is no reason that you should not sign up for this. If you do not get
your primary care here (at Housing works) then transfer. (Black woman, 35 years)
Participants took it upon themselves to spread the idea about the program. Some went
even as far as to claim a responsibility towards the community with respect to the
program. A 67-year -old, African American woman described how she considers herself
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lucky to be a part of the Housing Works community. She noted her need to spread
awareness about adherence to others who might still be misinformed or lack the support
that she has received from Housing Works community.
I am blessed to have friends and family. I am blessed to be a part of this
community. I feel I need to give back. I need to tell those who do not know about
HIV, I need to spread the word about good health and how happy you can be when
you are healthy. I am happy to be a part of Undetectables and now I want to give
back. At my age, you start to count your blessings and try to give back. (African
American woman, 60 years)
The feeling of being a part of a caring community and feeling responsible for its wellbeing can become powerful mediators of social change. For marginalized communities,
in particular, a community orientation can stimulate an orientation for advocacy among
the members which may lead to better collective bargaining for their rights (Ghose,
Swendeman, George, & Chowdhury,2008). Conceptualizing health and adherence as
outcomes and responsibilities of a community rather than that of individual choices has
the potential to bring forth noteworthy and sustainable change in the public health
outcomes.
One 62-year-old Black woman underscored how her personal experience with the
program was translating to something beyond herself.
I love myself, I take care of myself. I get that reward and keep it in my bag, I feel
very proud that I have done my bit to help me be healthy and get that reward in the
process. I feel we all need to do that, become healthy and stay adherent. I mean not
just take your own medicines but ask others to do it. I want to be a part of the team,
I want to tell people that you are worth the care, you deserve the reward.
We have described how the incentives were signaling self-worth in some participants
and how that translated into greater impetus to self-care in the earlier sections. Here we

71

see how that phenomenon is spilling over, or translating to, a sense of communal worth.
A notion of self-worth and ethic of self-care is being extended to peers and we notice an
urge to forge communal bonds and encourage a communal way of achieving better
health outcomes.
Similarly, the future orientation as discussed earlier had a community level
analogue. Some participants felt emboldened not only to imagine the status of their own
future selves, but also imagined a healthy, morbidity free future for the community of
PLWHA and others. The intervention with its impressive aims to improve adherence in
an effort to “End AIDS” found resonance in the thoughts of a 65-year-old African
American Man, who is heavily involved in advocacy, opined:
We can’t stop now. We are so near to the End of AIDS movement. There is enough
money. We can go on and end this epidemic, Housing Works can’t stop now.
Now that we have explored the symbolic value of the incentive and how it
motivates adherence, in the next section we look at the material benefits provided by the
incentive and how it motivates adherence.
Motivation through Material benefits. While discussing incentives, most
research focuses on the motivation to gain the incentives and its effect on behavior in
psychological terms. While organizational and corporate psychology research
underscores the value of size of the reward and the way it is dispensed (token rewards,
cash, salary bonuses, reduction in premiums, (Deci, Koestner & Ryan, 1999; Jenkins,
Mitra, Gupta, & Shaw, 1998) no study till date on financial incentives in the clinical
setting has discussed the material benefits provided by the incentive or how the
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incentive is used by the participant. The present study uncovered the ways in which
incentives were used and the results emphasize the importance of the material benefits
of the cash incentive as an important element in promoting adherence and other healthy
behavior. In the previous section, we discussed the symbolic and psycho-social
meanings attached to the incentive, here we explore the actual material implications of
the cash reward on the lives and behaviors of the study participants.
The amount of money received. Most of the study population lived on fixed
income and were heavily dependent on welfare benefits for their daily living expenses.
Given this situation, most of the participants deeply appreciated what they could do
with the quarterly 100-dollar card. One woman echoed the thoughts of several others’
when she said, “I try to make it last, you know, it is like having money in the bank. You
can buy things.” On being asked what he thought of the actual amount, a hundred dollar
per quarter, a 65-year-old Hispanic man said:
It is substantial. It is good. Of course, I would like more, but 100 dollars every
three months in great. It helps you to plan for things. It is not like a lunch coupon
for 20 bucks that just disappears, but enough money that can get you things that
you need (Mixed man, 47 years)
Another participant, a 45-year-old White woman described the cash in hand as “cool
little extra, I am very happy to have it.” It is useful to remember that the incentive
amount of 100 dollars per quarter or 400 dollars per year was decided with the aim for
the reward to be substantial, yet within the maximum amount transferable without
incurring extra tax liabilities for the recipients.
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What is done with the money? When asked how exactly the participants
used the money, they came up with a range of expenses that they used the money for.
Some participants reported how the extra money was used for food.
If you have an empty fridge then I get worried. I get some milk and bread when I
get the money. I keep the money for emergency, if I run out of cash and have
nothing to eat I reach out for it. (African American woman, 60 years)
Healthier diets. Specifically, some participants outlined how they used the
money to obtain healthy food.
My bills, sometimes they get overwhelming and I am on a fixed income. I try to eat
healthy but healthy food is expensive. You cannot live on junk food with this virus.
The money helps with that. I try to save it up for healthy stuff from Trader Joe’s, it
is not possible for me to get them otherwise. (Mixed man, 47 years)
He went on to further explain his use of the extra money to budget for a better diet:
I am in a group where we discuss how food helps your body to fight the disease.
You need to take your medicines, but you also need sleep and good food. I have
been very careful with my food. I use that extra money to buy fresh stuff, I take the
bus to get the stuff, you don’t get good stuff at the corner store. The bus costs
money and fresh food costs money so the card comes in handy.
Another 50-year-old African American woman mentioned how it was difficult for her
sustain her healthy diet and how the incentive amount helped her with food.
Since I have my apartment I try to cook fresh food, but 190 dollars not get you a
lot. I try to get coupons and my sister comes along to help me save. She drives me
to the stores. I plan ahead so that I do not run out of food. The money is good. I
save it and go to Walmart and get chicken and frozen vegetables, sometimes that’s
cheaper.
Access to healthy food continues to be a problem among the poor in the US (Walker,
Keane & Burke, 2010). For PLWHA healthy diet can complement regular adherence to
HAART leading to positive health outcomes. In this context, our participants reveal
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how intermittently (although inadequately) a financial incentive can help them obtain
food of their choice. Financial incentives can motivate some participants to obtain better
health outcomes by medical adherence and help them, in a limited way, to access
healthier diets.
Utilities and household expenses. A few of the participants reported how they
used the money from the incentive to pay bills and purchase necessary items for their
household.
I buy clothes, sometimes I buy stuff that I need around the house. I got a phone, my
phone broke so I got a phone with it. I paid my phone bill the next month. I have
used the money for paying for data, I use my phone to do face book and youtube so
I like to have data. (Latino man, 55years)
The incentive was used by a 65-year-old African American woman to defray the cost of
utilities and sometimes help out friend and family in need.
The money comes in very handy, you know what I mean. One month I had to pay
extra for electricity and I had the card, so used some of that. I have used the money
to buy new plates. One time my sister wanted a loan, I could help her as I had the
money. The money is very useful if you know what I mean.
Indulgences, self-care, and self-reward. Then there were others who used the
money to purchase items that would otherwise have been unaffordable. They used the
money to treat themselves to the occasional nice meals and buy consumer goods that
improve the quality of their lives.
I go for shopping, I go like to K –Mart or Target. I let it (the cash incentives) pile
up and then I get something big. I got a TV, a blender and a toaster.
Some participants felt that it was nice to be able to treat themselves to items that would
otherwise be an indulgence. One woman, in particular, had developed a ritual for
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rewarding herself with each incentive payment she received. She thus described her
ritual:
What I did, I bought a piece of jewelry with my first gift card something to
remember you know like why I do, what I do. With every gift card, I get another
charm to put on the bracelet. I feel very proud that I can do that, it is a reminder for
me to do good things. (Black woman, 42 years)
During the interview, the participant pulled out the bracelet from her purse, proudly
displaying the trinkets while identifying them with the month each ornament was
bought. She proudly put it on her wrist in front of me much like decorated soldiers
donning their service medals. The symbolic value of the material rewards that she had
devised for herself constantly reminds her of the task at hand while positively
reinforcing the desirable healthy behavior. The sense of self-worth and the ethic of selfcare is reinforced by such rituals of rewarding oneself with the money from the
incentive, an amount of money that participants perceive as rightfully earned reward.
Money for substance use. Substance use has been identified as one of the major
barriers for continual adherence to HIV medication (Hinkinet al.,2007; Mills et al.,
2006). Many participants in this study attributed their lack of adherence in the past to
substance use habits. Specifically, a 54-year-old African American woman reported that
there were times in her life that she sold her prescription HIV medication to obtain
“drugs from the street”.
I was undetectable before, then I became detectable because I stopped taking my
medication. I was selling it. The reason I was selling my medication was I was
short on cash and did not want to go out and prostitute myself, you know what I
mean. I sold the meds.
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She further adds,
I was using cocaine and needed the money for it. I was not taking the medication
anyway, I thought I may make some money with the meds on the street and buy
drugs. The money was very little, but I did not care. Any cash was good.

She goes on to describe her conflict with taking the medication and need to obtain the
substances she was addicted to: “I wanted to take them, but my need for money was
stronger.” Echoing her sentiments about the competing needs of staying adherent and
getting high, another Black woman (55 years old) describes how she thinks some of her
friends prioritize their substance use over medical adherence.
They are addicted to it. They need their fix and even when the know that my
medication is what keeping me alive, I still want my drugs. I tell them take your
meds or you will be sick. They are like we want to take our medication but in that
moment let me sell them to get money for crack. That’s how it works.
With the establishment of financial incentives, the need for trading the HIV medication
for cash was circumvented. The participant (African American woman, 55years) who
described her previous experience of selling drugs described the post intervention
situation:
You get 50 may be 20 on the streets. Yes, they still approach me on the streets for
the meds. I do not need that money any more. Pharmacies will buy them, people on
streets buy them and sell them to other countries.
Participants further pointed out that now to get some money they needed to take the
medication and that changed their urge to sell the medication for money.
Now I know I need to be undetectable to get the money, I take my medication
every day and that helps me. I still use sometimes, but not the way I used to. I am
healthy and I feel good. I do not have to sell my medication anymore. (White man,
57 years)
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It is useful to remember that Housing Works, the service provider implementing the
financial incentive intervention, utilizes a harm reduction approach and does not require
their clients to be addiction free to access services, but supports their de-addiction
process. In such a service environment, providing the clients with financial incentives
and not restricting what they can or cannot do with the money, respects their agency. It
can be interpreted as a refusal to turn clients (who are poor and many have a history of
substance use) into docile, compliant subjects who are forced into behaving in a
particular prescribed way by their providers. The participants respond to such an
empowering approach and appreciate both the material value of the money and its
symbolic import (see earlier section on motivation and symbolic significance). One
participant sums up the situation neatly when she says:
That’s another thing that the program has put an end to. Even if I am not smoking
or doing drugs, sometimes I could use that extra money. But knowing that my pills
are here and I have to take them to be healthy and get the card makes me want to do
it. (Black transgender woman, 60 years)
The issue of concomitant substance use and adherence to HIV care is complex and
needs multilevel interventions. However, as shown in the examples presented above, the
financial incentive can in certain cases provide material benefits that obviate the need to
sell medication on the streets to obtain money for substance use. The logical next
question is whether the money so provided enables participants to obtain substances.
When we asked this, almost all our participants agreed that it is a possibility. However,
none of the participants reported using the money for substances or know of people in
the program who were doing so at the time of the interview. They pointed out that
getting the incentive as a card and not in cash makes it difficult to use it to buy
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substances off the streets. Moreover, they stressed on the process of a reorientation with
regards to self-care and self-worth, as promoted by the financial incentive and the larger
intervention, as being deterrents to continued substance use. Adherence to medication
as promoted in the intervention was a gateway to the larger goal of remaining healthy
and taking care of oneself.
In the next two sections, the barriers and promoters for adherence as experienced
by our study participants are discussed. We point to how the incentive program in
particular and the intervention in general influenced (or failed to influence) each of the
factors.
Barriers
While reviewing the literature, we had noted several barriers to adherence. Here
we describe some of the common barriers that our study participants reported.
Forgetfulness. One of the most common reasons cited by participants for not
taking the pills is that they forget to take them. The urgencies of life made many forget
the box of pills. Such forgetfulness may signal that the pills were not perceived as one
of the most important parts of the daily routine.
People forget, people just forget. There it is in the box but life is happening too, so
you do not remember. People are busy taking care of their needs, they are looking
for ways to survive. The pills remain in the box and people just forget about them.
(Black woman, 55 years)
The incentive program may help some to realign their goals of daily routine in a way
that taking the pills become important. Being in the program, taking about adherence
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and being reminded of the benefits of adherence (the financial incentive being a part of
the immediate benefits) helps some clients to try and actively remember to take the
pills. Some people incorporate it with daily routines of meals and some others have
successfully made it a part of their morning or bed time rituals.
I take them at bedtime every day now. I keep it by the bed. I am more focused now
in taking the medicines every single day. I attend the programs and becoming
Undetectable is what I want for myself. Every three months I am reminded that I
have been taking my medicines every day. It is difficult to forget now. (White
woman, 45 years)
A few others would forget to take the pills even when they acknowledged the
importance of taking the pills regularly.
I know these pills are keeping me alive. I want to take them every day, like
clockwork. But my mind is shot, I forget, and when I get to bed at night I
remember. Sometimes I remember a whole day later. I used to feel so bad. (Black
woman, 62 years)

The medical provider has since then discussed strategies around missed doses with her
and she keeps a phone alarm to remind her of her daily dose.
Side effects of the medication. At the time of the interviews, none of the
participants complained of any significant side effects that they perceived as a barrier
towards remaining adherent. Most of them, however, reported having severe to
moderate side effects when they had started their therapy. All the specific complaints on
the side effects were adequately handled by their doctors and changes were made in
their regimens. A 37-year-old Black Transgender woman related how it was now easier
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for her to take the medications since the side effects from the time she started the
therapy no longer persist.
Hopelessness. Hopelessness was a recurrent theme identified as a reason for
individuals failing to stay adherent. They lacked the motivation to take care of
themselves through acts such as adherence to medications, since they believed that they
were going to die from HIV no matter what they do.
I just was in the give up stage. I felt that I was going to die anyway, so I just did
not want to take it. I was in a very low phase and I did not care much about
anything. (African American woman, 45 years)
While the incentive program alone could not possibly have prompted them to adopt a
more hopeful future, it may have helped in aligning short term behaviors with long term
hopes for the future (see above section on “symbolic motivation: future orientations”).
Fear of disclosure and consequent abandonment. One participant narrated
how she started missing multiple doses of her HAART medication.
But I was not taking my pill. It was something stupid, a boyfriend. I did not want to
pop it in front of him. After 2 or 3 days, I forgot where I stashed my pills and I kept
missing the meds. Yes, and then I went down, I have always been 1000 or better
(referring to CD4 Cell count) but then I went down. (Black transgender woman, 37
years)
She was unable to discuss her HIV status with her boyfriend. The fear of abandonment
made her hide her status and made it difficult for her to openly take the medications.
During the times when the boyfriend spent the entire day with her she would have to
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forgo the medications. She goes on to explain how her fears of abandonment led her to
further neglect her adherence.
It is not an easy thing to tell anyone, you find someone who wants to be with you
and you want him to stay by hook or by crook. You feel like no one is going to
accept you and you settle for this looser and then when it all begins, and you stop
taking care of yourself and hide your medications. (Black transgender Woman , 37
years)
After a health scare with rapidly plummeting CD4 count, she reassessed her life goals.
Her boyfriend guessed that something was wrong and finally she disclosed her status.
She finally broke up with the man and at the time of the interview claimed to “have
been foolish enough to kill myself to keep a man, never again.” This example perhaps
ends in a way that some may describe as positive (at least for the participant’s HIV
related health ) but signals to the continuing problems of stigma around HIV and
difficulties in disclosure. Fear of disclosure of HIV status has been reported by other
researchers as being one of the significant barriers to regular adherence (Weiser et al.,
2003). However, for our study participant this issue seemed less common. One may
speculate that the community orientation and empowered service environment of
Housing Works and its continuous advocacy for dignity and rights of PLWHA helps its
clients feel less anxious about disclosing their HIV status.
Grief and personal loss. Incidents such as the death of a partner, friend or close
family members could lead to a disruption of regular routines. While some clients
recovered quickly from such incidents and desired to get back their usual routines,
others were severely affected by the grief.
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My partner had died. That is when everything went downhill. That’s when my T
cells disappeared; they went down to 47. I went to live with my sister, she helped
me out. She took me to the doctors and they changed all my medication. My sister
would give me the medicines every day and the nurse would call up at times to
check. I slowly got better and then started taking my medicines on my own. (Black
woman, 54 years)
Though it is not possible for individual interventions to deal effectively with life events
such as that described by this participant, the presence of social support and a service
atmosphere which is supportive and responsive to individual needs can go a long way in
dealing with these issues. For this participant having a caring sister and being a part of a
care system that responded to her needs and prioritized adherence helped her get back to
track with her medications.
Apart from these barriers, no other significant barriers were reported by the
participants. We did not include substance use as a category here as participants did not
report it as a distinct category that they currently perceived as a barrier. We have
discussed in the section under material benefits how selling medication for drug money
was an issue with some participants and how the intervention was influencing that
problem. However, no one identified the use of substances per se as a barrier towards
maintaining adherence.

Facilitators
The environment of Housing Works, the policies adopted and the attitudes of
their staff members proved to be facilitators of adherence behavior. The VLS
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intervention as a whole was a major factor in ensuring better adherence, and financial
incentives interacted with the other components of the intervention to positively
influence adherence.
The context of Housing Works. Housing Works is a HIV focused, housing,
healthcare and social welfare service organization based out of New York city. The
organization dates to the time of the ACT UP movement in the 1990s that sought to
mobilize PLWHA for advocacy for better health care and policy reforms. The
organization continues the tradition of advocacy and community mobilization along
with quality service provision. The Viral Load Suppression (VLS) program (also called
the Undetectables program) was designed to improve adherence to HAART to achieve
high levels of viral suppression among its clients. Housing Works is an important
partner in the state wide effort to “End AIDS by 2020” in New York, and the VLS
intervention is deemed an important component of that endeavor.
Participants in general positively reviewed their experience with Housing Works.
Many compared their previous care access experience at other organizations with the
special care they currently received at Housing Works.
I was living in San Francisco, and I have never seen anything like this. The people
of here are amazing. They welcomed me and have made my transition to New York
easy. I appreciate how everyone here is respectful and they get their job done. I
appreciate the care they take while dealing with us. (Latino man, 56 years)
The organization provided an environment of care with efficient and empathetic staff.
Many clients also volunteer or work for the organization which fosters peer bonding
and a sense of a caring community.
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This is a place for people like us. You know if you are ready to help yourself, they
are there for you. If you do not come on nasty to people then people come forward
to help you out. They work with you in trying to solve your issues. I absolutely
love it here. (Black man, 42 years)
One participant narrates how the staff have helped her by going beyond her official
duties to make services available to her. She feels a deep sense of gratitude and wants to
contribute to this community.
Ms A bend the rules to get me in, I am so thankful. I have faced a lot of violence, a
lot of hatred for being HIV positive where I lived in North Carolina, but it is
wonderful here. I cannot thank God enough for leading me to these people. They
never make you feel like shit. They respect you for what you are and then you want
to do that for everyone. (African American woman, 62 years)
As a part of their policy, Housing Works has been a champion of Housing first
policy, which prioritizes providing stable housing first before any requirements of de
addiction is considered. The organization espouses harm reduction approach which does
not require clients who are substance users to compulsorily refrain from using, but
supports them in their de addiction process. Such an approach provides a sense of
dignity and respects the clients’ agency. Participants generally approved of such an
approach as being respectful and ultimately useful in their journey towards healthy
living.
Harm reduction is a good thing. I have been doing drugs for a long time. Doctors
and case managers have always been very weary of me. I have never felt
discriminated here. I can share my problems with my case manager for I know she
is not going to judge me. They do harm reduction here and that has made me feel
good about myself. (Black woman, 55 years)
A 62-year-old Black woman expressed a sense of hope, peace, and comfort she
experienced by being a part of Housing works. Such an environment helps her to follow

85

medical advice, plan her future and she views herself as an activist fighting for a
common cause.
We are a community of activists here you know. The kind of person I am, I want to
give back to these people, they have been wonderful about everything, they got me
the apartment have great doctors from here so I can figure out my life. I have had it
very hard, so I appreciate all the help I get and I want to become an advocate for
other people here. Housing Works has good doctors and case managers. I have
nothing to complain. I am very happy with the program. The service is tip top.
Some participants actively advised their friends to transfer to Housing Works given
the quality of their service. A 38-year-old Black man moved to New York to get
services at Housing Works and he does not regret the decision.
My friends if they ask me, I always telling them to transfer to Housing Works. I
moved here from Philadelphia to be at Housing Work. It has such great services. I
am very happy with the move. I wish we had such services in Philly. I feel very
good about coming here. You see these familiar faces and they ae friendly and
helpful and you know many of them as positives like you, it is a great place to
come to for your PCP.
The de-stigmatizing context of housing works is an essential facilitator for adherence
among its clients. The resources and services along with the context in which it is
provided helps clients feel respected, empowered and motivated to adhere to medical
advice received from Housing Works. The meaning making process associated with the
financial incentives as described earlier can operate in the particular environment made
possible by the policies, attitudes and norms of the service and advocacy organization.
Care Provider-Patient relationship. The therapeutic relationship has been
idealized as a partnership between the provider and the recipient of care (Pearson &
Raeke, 2000). Adherence studies have underscored the importance of the provider
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patient relationship as an important factor influencing the quality of adherence (Mills et
al., 2006). Our study participants report how their relationship with their care providers
- doctors, nurses, and social workers - have impacted their adherence practices.
In general, many participants reported being happy with their present care
providers. The intervention required all participants to be receiving their primary care
from Housing Works. While most participants were already recipients of primary care
from Housing Works at the time of inception of the program, some had switched their
providers to be able to join the intervention program. From the vantage of being new to
the system they compared their previous care receiving experiences to that at Housing
Works.
I like her (his current PCP) better than my doctor in Philly. I used to see him only a
few times a year, here she keeps me on my toes. I did not have the time to discuss
how my meds are treating me, now I talk about them all the time. My doctor, she
listens to me and I can be free with her. (Black man, 38 years)
The regular clinical visits and the renewed focus on adherence has helped many
participants in making better decisions about their adherence.
In particular, some participants described how the ease of communication with
providers have helped them to make deliberate, informed choices about their adherence
practices.
We have that kind of relationship. My doctor tells me, ‘you have to up it, the tests
are not good.’ I like that we can talk like this. I can tell her that I am not taking my
meds because I am stressed. Then she says, that even though you are stressed you
are supposed to take your medication, that is what making you live. (White man,
47 years)
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The participant stresses on the fact that unlike in the past, now he feels more
comfortable talking to the doctor regarding his issues around adherence. The increased
discussion inside and outside the clinic about adherence and the “virtues of being
undetectable” have empowered the participant to actively engage in his care decisions.
We have discussed how the intervention has created a perception of increase in the
level of care received among some client participants. Many noted the greater
availability of nurses and other clinical staff and their willingness to engage in care.
While describing his experience with the Directly Observed Therapy (one of the tools in
the intervention kit, discussed in the next section), one participant appreciated the ease
with which he can access some care giver over weekends now as compared to what he
could during earlier times.
I can now meet up the nurse through the weekends to take the medication. It is
wonderful to have that, not to wait for the next week to talk about your problem but
you can do so right away. It is easier to get hold of a nurse and have them listen to
you. (African American man, 55 years)
The case managers have always played an important role in the care coordination
and linkage to services for the clients. As a result of the intervention, they were now
more likely to have direct conversations about adherence to HIV medicines along with
providing other essential care and counseling services. All the participants expressed
their satisfaction with their case managers and identified them as major allies in their
journey to adherence, health and well-being.
I love Miss E, she is very nice. She always asks me, Mr. M have you taken the
medicines? How is everything going? I can trust her to do the best for me. I
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absolutely love that I have her as my case manager. I am thankful for all her help. I
am happier today and healthier because of what she has done for me over the past
year. (African American man, 65 years)
Specifically, with regards to the financial incentive, our participants reported little
change in their relationship with their care providers. This is an important finding since
some opponents of financial incentives claim that a financial incentive undermines the
quality of the therapeutic relationship. Incentives, they claim, can be viewed as bribery
from the provider to the patient. Given the unequal power relationship between the two,
the patient may feel coerced into following the directions under the sway of authority
and financial gain. The trust based relationship of care is impaired and it erodes to one
of transactional gains.
The participants in our study did report discussing the attraction of incentives with
their care providers. However, it was seen as a reward for their conjoined efforts at
securing good adherence and health for the patient.
My doctor tells me, you have to take your medicines every day. Let me know if
you have any trouble with any of the pills. I want you to remain undetectable and
get all the reward cards. I feel she has my best interests at heart always. I thank all
of them every time I get the card, it would not have been possible without them.
(Black woman, 62 years)

The VLS Intervention tool box. The VLS intervention provided concrete
tools/services to the patients to deal with their adherence issues. The tools consisted of
Directly Observed Therapy, Adherence Support Groups, and Text message reminder
systems. The program was also associated with an effective social marketing initiative
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that helped enroll and retain clients. The Financial Incentive was an additional provision
that was expected to motivate the clients in the context of the other adherence focused
services. Let us see how each of the tools and program components facilitated
adherence and interacted with the financial incentive scheme.
Directly Observed Therapy. As per the intervention protocol, patients who had
severe challenges with adherence could opt for a Directly Observed Therapy (DOT).
Here the patient comes in every day and takes the medication under direct supervision
of a nurse. Some may eventually come in once every week to check in with the nurse
after the initial daily visits when they feel more confident that they can regularly take
their medicines on their own. The participants who had taken part in the DOT arm
reported how it had helped them get back into the habit of taking the medication daily.
For the entire year, I came in to take my pills, earlier I would take it when I felt like
and miss it often. (Black woman, 50 years)
I would forget, just plain forget, but when I started doing this(DOT) every day, I
remember. I started to remember and it helps me remember now, because it is a
part of my routine. (Black woman, 42 years)
Participants recognized the demands on their resources of time and money
needed to come in everyday for DOT, however they generally acknowledged that the
benefits justified the costs.
I had to take the train every day to come in to Cylar House. That was not a
problem, it put pressure on my pocket but it was totally worth it. (Black,
Transgender woman, 62 years)
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Following daily DOT regimens, many participants whose adherence stabilized over
weeks or months, were set up with pill boxes. Participants could use pill boxes received
through the intervention (some had their own) irrespective of any DOT services. Pill
boxes came in handy for many of the participants especially when they were travelling
and staying away from their usual residences.
Here is my pill box, I have taken all the medication you know. This makes a
difference. I do not know what kind of difference but a very important difference.
(Black woman ,50 years)

Adherence Support Group. Adherence support groups were made available
through the VLS program. They used a combination of CBT and motivational
interviewing techniques with an aim to empower the participants and eventually hand
over the running of groups to the peers. Participants who were initially non-adherent or
have had relapses were encouraged to attend these groups. However, some of the most
regularly adherent participants also attended the groups and found the experience
useful. A Mixed-race man of 54 years exclaimed, “I like those. We talk about being
healthy, eating right and taking the medicines.”
The adherence groups dealt with issues of holistic good health in PLWHA while
underscoring the importance adherence to HIV medications. The peer led approach was
enthusiastically commended and helped secure the continued interest
participants/facilitators.

of the
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They let me facilitate one of them, I really liked that. I felt I was doing something
very useful. I look forward to doing more of those. (African American woman, 54
years)
Participating in these groups made some of the clients feel empowered with regards to
their disease and has inspired others to become advocates for good adherence behavior,
holistic health practices and well-being of PWLHA in their service community.
Well, my topic was becoming, staying, and remaining undetectable. I shared my
story and helped people become that way. (Black woman, 50 years)
Reminders. Two other of these intervention tools that were related to those
discussed above are the RINGO text message reminders and the “buddy system”. The
text message reminder was a system of DOT implemented through text message
reminders, where the participant receives a daily or weekly message reminding her to
take her medication. A 36-year-old Black man mentioned, “They send me a message
every day, that helps.” Another participant said:
I have not used the service, I remember on my own, but others have and I
recommend it to those who find it difficult. They say it really helps them (Black
woman, 50 years)

Forgetting to take the medication was one of the most commonly cited reasons for
uneven adherence, and these reminders helped in those cases. Participants themselves
devised alarm reminders on their phones to help them remember the time of taking the
daily pills. A 43-year-old Hispanic woman said, “I set an alarm and then the message
comes in, so I remember to take the pill.”
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Another source of reminders for the clients was from each other. In general, we
have noted how the increased discussion about adherence created an atmosphere where
clients, in contact with the system and each other, were now more likely to talk about
and hence remember to take their HIV medications. Furthermore, some clients formed a
buddy system through their adherence support groups where they have a peer in the
group – a buddy- and check in on each other via calls or text messages.
I have a friend ring me up. I ring her up too. We check on each other -have you
taken the pills? please take them. That’s like having a person care for you. (African
American woman, 56 years)
Family and friends who are not a part of the service community also check in with
participants and motivate and remind them to take their medication.
My daughters ring me up every day and ask ‘have you taken the medicines?’ they
love their father, I do not know why. My buddy also calls and checks in with me.
(African American man, 64 years)
Thus, the buddy system augments the existing social support, and enhances the chances
of better adherence among the participants.
Social marketing of the program. The VLS program roll out was accompanied
by a massive social marketing scheme. The complete description and analysis of the
effort is beyond the scope of the present study, however, here I briefly outline the major
effect it had on the uptake of the program and adherence among participants.
Housing Works started a social marketing campaign around the VLS project under
the name of the “Undetectables”. They had flyers and posters advertising the
intervention displayed in all the clinics and other housing works facilities across New
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York city. Additionally, they published periodic brochure designed as graphic novels
which documented the stories of the participants as they narrated their experience with
HIV medication in a bid to become virally undetectable. The women and men were
portrayed as super heroes with special powers that has led to their special undetectable
status. The idea was to promote interest in adherence and heathy behavior by reframing
them as super powers that makes one a super hero-The Undetectable. Such a social
marketing approach stimulated a lot of interest in some of our participants and they
enthusiastically recounted their encounter with super heroic fame.
I love them (the super hero comics). I want to be in them, my wife has been
featured. Yes, she was very proud. She was in the program (VLS) longer than me,
she got me into the program. She asked me to join. She was so excited the day she
got the book, she was in it. It is like I have super powers now, I am strong. She is
an advocate, she wants to go and talk to people about this. You also get the money
(laughs) and I get it too, so we have 200 for the house now. (Black man, 36 years)
The comics become a way for some participants to talk about adherence and their
other health issues with their family and friends.
The comics are very cool, she gets them home and gives them to her family, they
are proud. When she is sad she reads them. My wife is very fond of the comics. She
likes to draw, so she loves art, the books are her thing. I joined Undetectables after
she got me the books. (Black man, 36 years)
Identifying with the super hero characters activated some of the meaning making
processes around self-worth and self-care in a way similar to that of the incentive as
described earlier. A 37-year-old, Black transgender woman described the attraction of
the books in the following manner:
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I like to look good, trans women are very vain, they love their looks. I take care of
my skin and diet and my meds. It is like superwoman, we have the super women in
comic books at Housing Works. I think Trans women want to be that, super
women, we are big (laughs) and powerful, we want to beat this thing and use our
powers to get what we want.
Others appreciated the effort as an effective means to communicate with a younger
population. The following quote illustrates how an older adult (75-year-old, African
American man) used the comics to talk about himself with his grandchildren.
I am an old man, I do not read comics, but my grandchildren they love the comics.
You know Family Guy, yes. They saw the comic books and they liked it. I think
young people like the comic books. My son read that and saw the poster and he
asked me about this program. My grand -kids saw the comics. They asked me are
you like batman now? (laughs) I think they are good.
Some saw the comics as an excellent way to reach out to a more diverse population
with regards to age and literacy levels. A 65-year-old, African American man suggested
wider and more aggressive outreach using the comic books.
Why can we not have the comics all over the city? Not just at Housing Works, but
every at doctor’s and clinics. Young kids can pick it up and come get tested. You
asked what Housing Works can do for younger kids, they can circulate these
magazines. 15 -16-year-old kids can read this and get some idea. They can’t ask
their parents and they do not know everything about sex from school, so they can
read these and know. I think it is a good effort but Housing works should send them
to all hospitals and clinics.
The facilitators described above created the right environment for effective uptake
and engagement with the financial incentive program. In the next chapter, we will see
what implications this has for the future of financial incentive in theory, policy and
practice.
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Conclusion
The theory presented in this chapter explains the way financial incentives work
for the specific community setting of Housing Work clients who are living with HIV. It
brings into focus the dynamics of incentives, its constituent processes of symbolic and
material effects on motivation. The context in which such a dynamic works is also
explored in some detail. In the next chapter, the salient finding will be discussed in an
attempt to place the study in the context of other theories and suggest possible future
implications of this study.
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Chapter 5: Discussion
Introduction
Economists and other social scientists have tried to understand how incentives
work to motivate individuals to carry out behaviors in an array of settings, such as
schools, work places, consumer markets and health related situations (Giles, Robalino,
McColl, Sniehotta & Adams, 2014; Solomon et al., 2014; Ryan & Deci, 2000; Jenkins,
Mitra, Gupta & Shaw,1998). This study in the main sheds light on the process of
motivation for adherence in the context of financial incentives. The results have been
organized in two main domains: motivation derived from symbolic interpretations of
the incentive and motivation provided through the material benefits of the incentive.
Moreover, the context of barriers and facilitators to motivation as found in our sample
have been discussed. In the following pages, implications of each of the salient findings,
to better elucidate the dynamics of motivation as activated by financial incentives in a
clinical setting, are discussed. It is followed by a discussion of the implications of the
results specifically with regards to theory development, practice directives and policy
recommendations. We conclude with a review of the limitations of the study and
avenues for future research.
Decoding Motivation
Motivation research can be traced back to the experiments of Skinner whose
work on operant conditioning laid the basis for behaviorism movement in post war
psychology (Skinner, 1963). The idea was that by reinforcing certain behavior with
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rewards, one can strengthen or reinforce that behavior (Wolf, Risley & Mees, 1963).
Scholars have since questioned the applicability of Skinnerian models, which was
developed mostly from animal testing, to humans in complex social settings (Staub,
2016). Later work on intrinsic motivation (see Chapter 2 for detailed discussion) has
maintained that external rewards can crowd out intrinsic motivation resulting in less
diligent pursual of behavior that is reward contingent. Economists have disagreed with
this view claiming that external rewards may indeed be the rational choice for
individuals which work by increasing higher marginal gains on performance (Fama&
Jensen, 1983). Financial incentives for health behaviors provide an immediate reward
for an action which is construed to be beneficial in the long term. Humans have a
present bias which means that they seek more immediate rewards in the present than
wait for supposed long term gains(Kamenica,2012). The study participants recognized
this phenomenon and appreciated both the immediate gain of the reward as well as the
long-term benefit of regular adherence. An alternate theoretical understanding of this
phenomenon can be gained by looking at ideas of delayed versus immediate selfgratification. Mischel’s experiments in the 1960s which have been dubbed as “the
marshmallow experiments” have been influential in the discourse of delayed selfgratification (Mischel, Ebbesen, &Raskoff Zeiss, 1972). In these experiments, children
were offered an immediate but relatively small reward (such as one marshmallow) or if
they waited for fifteen minutes then a larger reward (two marshmallows or something
more substantial). The experimenter left the room after explaining the initial condition
and the child was left alone in the room with the first marshmallow. The time each child
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waited till they ate the first mallow was noted. Tracking the children over the next
several years, researchers found that those who managed to delay their gratification and
opt for the delayed larger reward had better life outcomes in terms of SAT scores,
educational outcomes, and body mass index among other life outcome measures
(Ayduk et al., 2000; Mischel, Shoda, & Rodriguez, 1989; Schlam, Wilson, Shoda,
Mischel, &Ayduk, 2013; Shoda, Mischel, & Peake, 1990). In 2012, the experiments
were recreated but with one significant difference (Kidd, Palmeri & Aslin, 2013). One
group of children was given a broken promise before the marshmallow experiment (the
unreliable test group) and the other was given a fulfilled promise before the experiment
(the reliable test group). The children in the reliable test group showed longer waiting
times for the second marshmallow to appear than those in the unreliable test group.
These results have raised questions about how delayed gratification may not be a
function of individual self-control but influenced by the environment. In other words,
for some delaying gratification may not be a rational choice given the unreliability in
their environment of obtaining the rewards in the future (Staub, 2016).
We propose that financial incentives for marginalized, poor people with chronic
conditions like HIV, provides a form of immediate gratification. For them, the chaotic
insecure environment of welfare benefits, unstable housing and uneven health care
creates an incentive to accept immediate benefits rather than laboriously cultivate selfcontrol and modify present behavior to live out a distant, uncertain future. The
immediate gratification motivates them to pursue the incentivized behavior which may
subsequently be appreciated as a long-term investment in their own health and well-
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being. Participants of such an incentive program may gradually begin to imagine futures
(some may have already imagined a future as our results show) which they perceive as
being less chaotic and amenable to some degree of present control through actions such
as adherence which maintains their health and contributes to their longevity.
Self-worth
Low self-worth or self-esteem has been, for a long time, correlated with adverse
health outcomes (Mecca, Smelser & Vasoconcellos, 1989). Later research has sought to
nuance the understanding of self-esteem and self-worth and its influence on
psychosocial outcomes (Crocker & Knight, 2005; Crocker & Wolfe,2001; Rosenberg,
Schooler, Schoenbach & Rosenberg,1995). However, researchers generally agree that
self-worth is influenced by how individuals are perceived by social others. Approval
from significant social others usually positively influences the perceived level of selfworth (Crocker & Wolfe,2001).
The results from this study demonstrate how a service and care based
intervention can provide approval and validation of self-worth for certain individuals.
First, some participants appreciated the increase in focus and quality of adherence
related services. This increase in services and concentration of care was perceived as a
novelty and a marker for the regard the care providers held for the well-being of their
clients. Second, the provision of the financial incentive in itself sent home a message
that the providers were not only committed to provide services but also actively approve
and reward of the client’s effort to engage in them. Both- these perceptions led some
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clients to appreciate their own self-worth and boosted their desire to engage with the
providers as deserving consumers of care.
While the recent study by Greene et al., (2017) reported how participants in an
incentive program perceived the incentive as a sign that someone really cared for them,
the significance of such a process uncovered by the present study assumes special
significance given that the participants were welfare recipients and relied on state
sponsored HIV care services. In the United States under the means tested welfare
system, welfare recipients are perceived as helpless dependents at best and as lazy free
riders at worst (Blau & Abramovitz, 2010). In such a context, the intervention with its
host of services and the financial incentive was deemed as a special effort to help clients
gain better standards of adherence and through it, good health and well-being. Without
stigmatizing them, the intervention sent out a message that one was worthy of good
health care services and one deserves to be rewarded in an immediate and concrete
manner (through the incentives) for actively seeking the services and successfully
engaging in the shared goals of better health. The intervention, thus, supplied an
example of how provision of services can foster a sense of self among the recipients
that can go beyond the stigmatized dependent and articulate one of a rights seeking
citizen, who can demand better care and refuse to be devalued and written off as
liabilities of the state.
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Self-care
Related intimately to the perception of self-worth was the urge to self-care.
Though it is not directly derivable from the results of this present study, there is an
intuitive appeal in the idea that all things being equal, a greater sense of self-worth can
result in higher levels of self-care. As indicated by the results, this urge to self-care
formed the main impetus to greater adherence behavior in many of the participants.
Self-care has been theorized most famously by Dorthea Orem (1991) who
considered it as a necessary idea to conceptualize nursing care goals and practices. She
defined self-care as activities undertaken by individuals on their own to maintain life, health
and well-being (Orem, 1991).It follows from her concepts that while every patient needs to
engage in self-care, there may be deficits between the ability for self-care and the needs for
self-care. Nursing interventions were understood to meet this need. Building on Orem’s

theories and adapting them for chronic diseases, Reigel, Jaarsma and Strömberg (2012)
suggest that self-care consists of maintenance, monitoring and management activities.
Adherence to best care practices fall under self-care maintenance. Health care
interventions for chronic disease patients must focus on adherence to maximize the
therapeutic effects of treatment and ensure long term well-being.
The results show that many participants identify adherence as being a necessary
part of their self-care routine. Moreover, many participants claim to engage in wider
activities, such as maintaining personal hygiene, eating healthy and exercising to
complement their HAART adherence practices. The broader VLS intervention provides
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them with tools for better self-care (such as support groups which discuss how to live
healthy with HIV) and the financial incentive provides them with an immediate short
term reward to stay the course of adherence. While we cannot claim that the incentives
directly stimulate other self-care routines apart from adherence, it has been a common
finding that health behaviors occur in clusters (Pronk et al., 2004). Hence, the
participants claimed that they engage in greater self-care along with adherence, with the
incentive providing a direct motivation for better adherence. Most participants who
reported self-care identified the desire to remain healthy, while a few explicitly claimed
that self-care was an essential path to ensure they looked good. These different
articulations of the goals for self-care can provide useful guidelines for practitioners
when they engage patients in counseling for self-care.
Taking a further step in the discussion of self-care, the political and advocacy
implications of a self-care ethic are critical issues to keep in mind. Neo liberal ethos
promotes self-care as a means to create increasingly efficient and productive human
bodies and minds. There has been a marked rise in the cult of physical exercise, yoga,
celebrity endorsed healthy diets and self-help psychology books which cater mostly to
the middle and upper middle classes. While promoting healthy behaviors in themselves
cannot be harmful, self-care regimes as indexed by the phenomenon mentioned above,
can be seen as an economy of indulgence in which only the well-off can participate. The
radical black, feminist thinker and political activist, Audre Lorde, provides us with a
counter narrative when she says, “Caring for myself is not self-indulgence, it is selfpreservation, and that is an act of political warfare” (Lorde, 1988). Some consider the
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marginal citizen a liability for the state (such as welfare recipients and recipients of
Medicare and Medicaid in the US) who can be easily dispensed with. When individuals
engage in self-care, according to Lorde, self-care becomes an act of political activism.
By perpetuating one’s existence (and thriving) through acts of self-care they defy the
powers that be, which may as well have them dead if not through overt acts of violence
then by systemic negligence and structural deprivation. We argue here that for our
participants self-care has a similar political possibility. Given that they were poor,
stigmatized welfare recipients and mostly identified with nonwhite races, they are
eminently the disposable citizens much reviled by the neo liberal state. As they gain in
self-worth and engage defiantly in self-care activities, both of which this study found to
be influenced by the intervention and financial incentives, one can argue that they are
engaging in grassroots political advocacy on behalf of themselves and similarly
marginalized groups within the US polity.
Future orientations
Imagining futures amid the chaotic present-day environments motivated many
participants to adhere to their medication regimes. As discussed earlier, the short term
financial incentive to act in the present helps individuals align their behaviors for
benefits in the future. Furthermore, as discussed in the results, participants thought of
both a healthy promising future which they could be a part of, by maintaining
adherence, as well as a hazardous, morbid future that they may actively forestall by
engaging in adherence and other self-care behaviors.
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While some studies on adherence have noted the role of future orientations as a
predictor of adherence (Mills et al., 2006; Remien et al., 2003), our study explores the
phenomenon with regards to motivation in some detail. Sandberg and Corner (2008) in
a meta-analysis of studies employing the Theory of Planned Behavior (TPB) identified
Anticipated Regret as a significant and independent predictor for intention in addition to
the TBP variables. Regret is defined as “a negative, cognitive-based emotion that is
experienced when we realize or imagine that the present situation could have been
better had we acted differently” (Sandberg & Corner, 2008). Regret can also be
anticipated before an action to avoid an unpleasant future and disagreeable emotions
(Simonson, 1992). Hence future adherence studies should further explore the role of
anticipated regret and a future orientation to better understand, predict, and modify
motivation for adherence behaviors.
Community orientation
The Theory of Planned Behavior identifies norms as an important predictor of
intention and behavior (Ajzen, 1991). A desire to conform to social/community norms
can become a powerful way to alter behavior (Linnemayr & Rice, 2016; Allcott, 2011).
We find that the VLS intervention served to positively modify the community norms
about adherence with participant clients and their providers focusing on adherence and
its importance in their care plans and goals for well-being. The incentives encourage the
uptake of adherence behaviors among the clients and some clients talk about the
incentive program to encourage other community members to join the program and stay
the course of adherence.
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The increased sense of self-worth, the urge to greater self-care and a future
orientation was translated from the level of the individual to that of the community.
Some participants claimed that they were now more concerned with the health and the
future of the community of service recipients at Housing Works and urged each other to
engage in self-care and adherence. While such a community orientation must have
existed prior to the intervention given the history and the approach of the service
provider community at Housing works, we can attribute the focus developed on
adherence at a community level largely to the VLS intervention program.
Bandura (2000) identifies collective efficacy as an important vector of human
agency.
People's shared beliefs in their collective efficacy influence the types of futures
they seek to achieve through collective action, how well they use their resources,
how much effort they put into their group endeavor, their staying power when
collective efforts fail to produce quick results or meet forcible opposition, and their
vulnerability to the discouragement that can beset people taking on tough social
problems.

The VLS program resulted in a perceived increase in the collective efficacy to adhere to
HAART medications and ultimately to eradicate the AIDS epidemic. Along with the
political activism of self-care and seeking better health services as a matter of social and
political right, the collective approach towards HIV care harks back to the history of
HIV activism and has enormous potential for mobilizing different groups of people in
an effort to contain the HIV epidemic and improve the life outcomes of PLWHA.
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Material benefits
The reasons offered to explain motivation provided by incentives have been
largely psychosocial with one only study recording how participants appreciated the
financial benefits from incentives (Greene et al., 2017). Our results show that for
indigent people with fixed income through welfare benefits, the actual value of the
money from the incentive is an important component of motivation. The money was
used to obtain better diets, defray personal costs, and also used for otherwise
unaffordable luxury items for self-reward.
Previous research has demonstrated the enabling effects of food assistance, in
particular, for better adherence in HIV and tuberculosis patients (de Pee, Grede, Mehra
& Bloem, 2014). Incentives utilized for food and other needs by poor patients can
become useful ways to ensure better outcomes and motivate adherence behaviors in
them. The material benefits derived are thus irreducible to exclusive psychosocial
understandings of symbolic value and intrinsic motivation parameters.
Provider patient relationship
The opponents of financial incentives have raised concerns about how it may
erode the trust based relationship of the therapeutic alliance between the patient and the
provider and reduce it to mere calculated transactions (Oliver & Brown, 2012; Marteau,
Ashcroft & Oliver, 2009).The participants’ experiences oppose that view. Many of them
described the sense of comradeship with their providers as they jointly made plans for
better adherence. The participants reported how their doctors, nurses and case managers
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discussed the benefits of the program in general and financial incentives in particular,
and motivated them to earn each incentive by diligently attending to their adherence. No
participant perceived a sense of coercion via the incentives from their care providers.
The providers encouraged them to view the incentive as their rightfully earned reward.
The patients thought that the providers themselves took pride when their clients claimed
the reward at the end of each quarter and considered it as a triumph of their therapeutic
alliance.
These results underscore the importance of the approach of the providers and
their acceptance by the clients for the success of financial incentive programs. Even
when we acknowledge the power differential between marginalized clients and their
providers who act as gatekeepers to services, the value of a partnership approach to the
therapeutic relationship cannot be undermined. The clients have no choice but to
assume that the providers are competent and have their best interest at heart while
administering care. They however, can be further reassured and motivated to adhere to
the prescriptions and advice if they are treated with respect and dignity, as agents of
their own care rather than passive recipients of the ministrations of providers.
Context of Care and Financial Incentives
The major reason financial incentives seem to work under the VLS intervention
scheme, is the way they were provided and the attitudes and policies of the provider
organization. The clients were presented with a whole range of adherence focused
services (support groups, DOTS, text message reminder systems) which aided them to
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get over barriers such as forgetfulness, isolation, apathy and lack of information about
medication effects. We propose that the financial incentive can only work in a context
where other services are in place that help clients with their medication adherence
issues. The financial incentive is an additional source of motivation, but it cannot
substitute medical and other social services that help clients with their individual
problems in maintaining regular adherence. Neither should we assume that the services
and incentives could provide a fool proof and comprehensive solution to all individual
barriers such as personal loss and grief, idiosyncratic reactions of HIV medications and
other unforeseen life events which disrupt regular adherence goals. Comprehensive care
remains the only long term solution to poor health care outcomes.
The context of Housing Works with its focus on harm reduction and grassroots
advocacy also formed a major source of support and inspiration for the clients. The
incentive program was well received since the clients were not made to feel like
stigmatized benefit recipients but deserving candidates for care and the attendant
financial incentive. The dignity and autonomy of the clients were respected in the
organization which had salutatory effects on the uptake of the program and facilitated
the positive, self-validating effects on individual clients. Moreover, the intimate nature
of the service provision environment facilitated client motivation and helped them to
positively view the financial incentives. Research has shown that incentives work better
in smaller clinics (El-Sadr, Branson, & Beauchamp, 2015) rather than larger ones where
the care though competent, may be perceived to be impersonal.
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Equity and decommodification
While we propose that the material benefits of the incentive for poor clients
cannot be ignored, the benefits derived cannot be exclusively understood through
material terms of utility and increase in purchasing power. The meanings attached to the
incentive creates more than transactional values. In a manner, the money provided
decommodifies the recipients as they made sense of the incentive and converted it into
instruments of self-worth, self-care and self-reward. Decommodification is a term first
used by Esping-Anderson (1990) to describe the different welfare state regimes of
developed nations. It can be understood as a way for individuals to escape the state of
being reduced to labor for sale in market economies. Decommodified subjects become
citizens with rights to a basic standard of living. While Esping-Anderson used
quantitative data to obtain indices of decommodification, here we employ a qualitative
use of the concept. The VLS intervention created an environment where marginalized
and socially devalued individuals accessed quality care and they were given direct
financial incentives to engage better with that care and follow its prescriptions. In a way
such an intervention, when funded with public money, seeks to extend the
responsibilities of the Welfare State. The State is not only deemed responsible for
providing quality health care but actively spends public money in engaging the clientcitizens in that care. The State strives to provide curative measures for the
disadvantaged (like it does with affirmative action) to promote equity. Fundamental to
this approach is the recognition that those who are disadvantaged by long standing
structures of racial, economic, and social inequalities need additional assistance to meet
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their needs for health and well-being. In justifying the right of their citizens to access
that care and get incentives for accessing that care, the Welfare regime is recognizing
their hitherto marginalized citizens as rightful claimants to its resources.
Implications for Theory – filling the gap
This is one of the first studies to qualitatively look at financial incentives for
adherence to HAART in people living with HIV/AIDS. The other recently published
work by Greene and colleagues (2017) also looked at financial incentives and adherence
to HAART, but the present study differs from it by engaging in a deeper analysis of the
issue and by employing a constructivist grounded theory framework it developed a
situation specific middle range theory for the phenomenon. It offered a more nuanced
understanding of the influence of incentives on motivation than previous theories in
three major respects.
First, it provides specificity for the clinical situation. Other financial incentive
theories have been based largely in education and work place management. It arrives at
concepts such as self-worth, self-care, and community and future orientations as ways
to explain motivation. These concepts have been studied by behavioral physiologists
and medical sociologists, but never in conjunction with medical adherence and
incentives.
Second, it brings together both psychosocial theories of symbolic worth as well
as materialist explanations, in one theory, to explain adherence behaviors. It explores
both individual level phenomenon and links it to broader environmental issues such as
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context of service provision, provider patient relationship that influence outcomes. The
broader socio- economic factors of gender, race and class have been hinted at during the
analysis, but these factors could not be adequately explicated through the present study.
The section on limitations and future research further discusses this issue.
Third, the study offers some answers to the debates on financial incentives. It
examines the effect of financial incentives on the therapeutic relationships: whether
incentives are perceived as bribery or coercion by the participants and how incentives
affect the provider patient relationship. Although not directly answering the question, it
also offers a way to frame an argument for the social and political desirability for public
spending on incentives.
The study inaugurates a new perspective on the research on incentives. It calls
into question both the rational transactional model of behavioral economics, as well as
the highly psychologized approaches of intrinsic motivation and individual control seen
in education research. Research with incentives for patients in the clinical settings thus
challenges, synthesizes and posits a different, more nuanced approach towards
imagining the effects of incentives on individual’s behaviors. Future research strategies
to refine and validate the theory presented in this study is discussed later in this chapter.
Implications for Practice
The theory developed from this study helps us understand the dynamics of the
process of motivation for adherence in PLWHA. Practitioners caring for people with
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HIV can engage with their clients in discussing the specific aspects through which
motivation for adherence is conceptualized to work in the specific clinical settings.
Given how self-care emerged as an important aspect of motivation to adhere,
doctors, nurses and social workers should focus on the aspects of self-care and explore
how patients can adopt self-care routines. Encouraging the patient to imagine adherence
as a part of a more general self-care plan can help initiate and maintain adherence and
other evidence based care practices. Motivational interview techniques can be used to
elicit the goals of self-care routines and help patient work through challenges and
barriers. Different patients may have different goals for engaging in self-care (looking
good, enjoying good health, living for others, avoiding morbidity and disability) as
shown by the results, hence, providers need to elicit and discuss these with their patientclients. Orem’s theory of care in nursing practice claims that nursing care is basically a
way to bridge the gap between capacities of self-care and the need for care (Orem,
1991). Especially for chronically manageable diseases like HIV, where most patients do
not need intensive everyday medical care from professionals, practitioners can expect
better health outcomes from inculcating an ethic of self-care among their clients.
When discussing the goals of self-care, practitioners must also consider the role
of future orientation as discussed earlier. Counselors should engage the clients in
discussing how they imagine their futures and encourage them to break the link of
fatalism to adopt more proactive approaches to the future by adopting adherence and
other health behaviors. Such future orientated discussions will necessarily involve more
than just health practices and that is where social workers with their diverse skills can
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help address the patient’s concerns about future contingencies such as housing, financial
planning, and geriatric care issues.
The results from this study reemphasize the role of patient centric approach to
clinical care. Acknowledging the patient’s autonomy and agency will be key factors in
obtaining buy in from the patient which will ensure better adherence to clinical advice.
Moreover, approaches such as harm reduction is found to be useful in dealing with
chronic substance use and may be better suited to achieve sustainable outcomes rather
than traditional methods of compulsory de-addiction.
Advocacy for health care rights and mobilizing for community norm changes
will be important ways to deal the issues of HIV especially among disenfranchised
populations. Advocacy cannot be imagined as an exclusive activity for a few.
Practitioners and clients can make it a part of their basic approach to HIV and health
related issues with an aim of expanding the range of available services and enlisting the
support of major stakeholders.
Implications for Policy
The study demonstrates the feasibility of a financial incentive program for
adherence and identifies key areas through which such a program can work. In terms of
scaling up of such a program, our study provides some important insights. First, the
incentive works best when provided within a context of other services that help clients
with their adherence issues, hence, standalone incentive programs may not succeed. The
incentive is an additional benefit that motivates individuals and secures their buy in, it
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cannot on itself, overcome the barriers of uneven clinical care, difficulties in access to
care, side effects from medicines and other such barriers to adherence. Financial
incentives cannot come at the cost of good medical services and as such requires outlays
that may not be available in resource limited settings. Second, to allow the positive
meaning making processes of improved self-worth, self-care urge, community
orientation and future planning, the context in which incentives are provided should be
carefully considered. The attitude of care providers towards the clients should not be
one of transaction and impersonal service provision. The recipients should not feel
stigmatized for receiving incentives (as welfare recipients do in the US) but be made to
feel worthy candidates for well-earned rewards. Smaller, community clinics are perhaps
best suited for such incentive programs rather than large hospital based clinics where
the service is mostly impersonal and does not provide for the non-medical needs of poor
clients. Third, social marketing programs and community tailored outreach services
may be essential for enrolling and sustaining participants in such a program.
As a conditional cash transfer tool, financial incentives for health and other
socially desirable behaviors have been shown to be successful (e.g. Opurtunidades in
Mexico (Fernald, Gertler & Neufeld, 2008)). Financial incentives can become a viable
policy tool in supplementing standard income supplementation programs. If adopted as
a part of the service packages (and if well implemented) it may not only improve health
outcomes, secure buy in and promote sense of self-worth among recipients, it has the
potential to help out financially (although in a limited manner) those who are on welfare
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benefits. Coupled with budgeting and financial planning trainings it can empower
clients to better manage their health care as well as plan their economic futures.
Changing community norms and securing buy in will require more than
individual based approaches to behavior change. Structural issues that affect health
(poverty, racism, stigma among others) need sustained community level interventions
and advocacy to bring about a change in the social and political will. Advocacy and
community mobilization, thus, should be an essential part of any health intervention
policy especially with marginalized communities.
Limitations of the study
This study was a part of a larger project which qualitatively evaluated the
feasibility and effectiveness of VLS intervention. The present study captures a
subsection of the data which focuses on understanding the process of financial
incentives in promoting adherence to HAART among marginalized PLWHA. A
qualitative exploratory study is undertaken to understand the basic concepts involved in
a process, and it cannot make claims of definitive causal explanations. Moreover, since
the population under study belonged to a very specific category, the clients at an urban
HIV-based housing and health service organization, the results remain context specific
and cannot be generalized to larger, more diverse populations.
Methodologically, the study had three major drawbacks. First, we relied on the
organization to recruit participants. We could not obtain a sample which adequately
represented the entire client base participating in the intervention. The responses in the
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study are mostly positive towards the program and it may be assumed that only clients
who were enthusiastic about the intervention consented to participate in our study.
Theoretical saturation was reached, however, a thorough exploration of the “negative
cases” or disconfirming evidence (experiences of dissatisfaction with the intervention)
could not be carried out. Social desirability bias could have influenced the mostly
positive responses from the participants even though it was made clear during the
consent process that the research is being conducted by a third party, who will not
report any identifiable information to the service providers. Second, due to logistical
issues at the time of writing this report we could not perform member check in focus
groups as originally planned (we plan to do it in the near future). Third, although we
had planned to have multiple researchers look at the results and perform rigor checks
such as inter-rater reliability, logistical issues prevented us from doing this extensively.
Apart from me, another researcher has gone through the transcripts and we have
discussed the codes and themes, but extensive and rigorous inter-rater reliability could
not be undertaken.
Another basic issue with conducting this research was the socioeconomic and
cultural differences between me, the researcher, and the research participants. Usually
this problem of distance between the researcher and the researched is debated
extensively in anthropology where ethnographic methods are employed. Moreover, the
concerns are more pronounced when the researcher is from a developed country and
engages in research in the global south. Here, I, the researcher was from India, a
developing country, and came from a privileged middle class background and was
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researching participants who were the urban poor in a developed country. Although, I
am fluent in the primarily language used by the participants and have received extensive
training in the US, the difference in shared references of culture, language and history
cannot be entirely overlooked. While it may be never possible to imagine what the
results would be if I came from a background closer to that of the participants, efforts
were made to be self-reflective and culturally sensitive at every step of the research
process. I had spent considerable time with other research projects at Housing Works,
and within the limited scope of these interactions, had gained some familiarity and
insight as to the organizational and socio-cultural mores of the agency and the clients it
serves. By the time I embarked on this particular research project many providers and
clients at the agency knew me, hence I was not a rank outsider, but a somewhat familiar
research partner. Through the research process, I maintained a research journal where I
recorded the settings, mood and details of the interaction that happened before and after
the interview. These were my guide to pick up clues about how my presence or
interaction was affecting the nature of the interviews. Though such clues or approaches
can hardly be systematized, I used this journal to debrief with my mentor and research
peers with an aim to detect issues such as leading questions, social desirability, micro
aggressions and my attitudes and responses to them. Given that I was the sole
researcher, collecting, transcribing, and analyzing the data, there was no way I could
blind myself to the details and the person specific contexts of the participants while
analyzing their responses. It may be argued, that constructivist grounded theory allows
for the co-construction of meaning between the participant and the researcher
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(Charmaz, 2006), and blinding processes during analysis which may offer rigor to some
other methods of qualitative enquiry, may not be best suited to the purpose of grounded
theory.
In the analysis of the data from the interviews we find references to gender, race
and socio-economic status issues. For example, an African American man exclaims that
the VLS program makes him feel like a “white mama”, transgender women identify a
desire to look good as a motivation to self-care, and most participants value the money
from the incentive given their fixed incomes. However, the present study does not
exhaustively engage with these issues. Given that this was an exploratory study and it
sought to gain initial insight into the processes at work to explain the role of financial
incentives on adherence, the present study should be viewed as the ground work for
further consolidating our knowledge of financial incentives. The underexplored
social/structural factors of gender, race and socio-economic status should be delved into
in the future research on incentives.
Future research
The next steps to follow up on this initial exploratory study will involve both
qualitative and quantitative studies further exploring the connections discovered by this
research. Qualitative studies can use the themes from this study and explore their
applicability to other more diverse populations within and outside the U.S.A. Further
refinement of the themes and their context specificity can be examined through
multicenter qualitative study with more diverse participants in different service
conditions. As stated in the previous section, social structural factors of gender, race,
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socio-economic status need to be explored more fully. Surveys can be developed using
the themes elicited through the present study to quantitatively validate the connections
indicated by this study. Longitudinal quantitative studies can be designed to explore and
substantiate causal claims between motivation and the symbolic and material
interpretations of incentives. Intervention programs can be designed with the theory
proposed by this study after it has been validated through further qualitative and
quantitative research.
Conclusion
The HIV/AIDS epidemic had ushered in a new brand of patient activism in the
US which has revolutionized the way public health, biomedical research industry and
care providers respond to a new disease. As we enter the fourth decade of the epidemic,
large sections of the US population continue to be disproportionately affected by the
disease. The availability of effective and relatively safe medicines to control the disease
and improve the health outcomes of those affected is an encouraging development.
Ensuring adherence to those medications (HAART regimes) has thus emerged as an
important challenge in the continuing fight against HIV. Service providers and policy
makers are now focused to find new and improved ways to engage and sustain HIV
positive individuals in a regime of care to improve their life outcomes with respect to
the disease, as well as, prevent the transmission of the virus to the uninfected. Financial
incentives, in the context of comprehensive medical and social services, have the
capacity to motivate individuals to better adhere to HIV medications resulting in better
health and well-being for longer periods of time. Incentives also hold the possibility to
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promote, albeit in a very limited way, social equity and intervene at micro, meso, and
macro levels of poverty, discrimination and stigma perpetrated by extant systems of
welfare, racism and social stratification. Understanding how financial incentives can
work will help us to better implement interventions using such a tool. This study was an
important step in that effort.
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Appendix 1: Interview Guide
Interview guide: Qualitative in-depth interviews with VLS clients
(This is a general guide for the kind of questions to be asked Each theme should be
explored, order and the exact nature of questions will vary for each intervieweeinterviewer pair )
Introduction
Introduce yourself. Explain the study, explain confidentiality, seek informed consent.
What is your name? what do you want me to call you during this interview?
How long have you been a client at HW? How long have you been a participant of the
VLS/ Undetectables program?
Brief history of experience with HIV
Do you recall when you first came to know about your HIV positive status?
How did you feel then?
How long ago did you start HIV-meds (HAART)?
How did you feel when you first started the meds?
Issues with adherence
At present how many pills do you have to take every day for HAART? Can you name
them and tell us roughly which do you take when?
Any other medication that you need to take every day?
How difficult or easy do you find taking the medicines every day?
Tell us about some of the challenges.
Intervention and its effects
Remind me, how long have you participated in the VLS/Undetectable program?
What are some of your experiences with this program?
How do you think it has affected your plans for adherence?
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What do you think about the quarterly cash incentives that the program rewards its’
participants with?
What do you think people who receive that money, do with it?
Do you attend the adherence groups? When was the last time you attended?
What are your thoughts about the adherence groups?
What are the things you discuss in the adherence groups?
Compare your experience with HW before and after this program.
Feedback/Recommendations
Any thoughts on how this program could be different?
Any changes that you would like in the way/amount of the cash incentives are presently
set up?
Any changes that you would like to see in the adherence groups?
Any thoughts for your providers (case managers/doctors/therapists) of what they can do
differently in this project.
What do you think is working for people who have been able to reach undetectable
levels?
What do you think is not working for people who have not been able to do that?
What are the ways in which HW can encourage more clients who are eligible to join
this program?
Any other thoughts/ recommendations?
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Appendix 2: Demographic Sheet
Participant number

Age
Gender
Preferred pronoun
Race
Ethnicity
Year of HIV diagnosis/how many years
since diagnosed
Current status with Viral Load
Current Housing status

History of incarceration

History of substance use

History of mental health disorder
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Appendix 3: Notes from the Research Journal

Initial codes – line by line, incident by incident
Case workers checking in about adherence - changing focus

“that’s why they have this program because I am not the only one”- feeling less
isolated-community feeling” - rightful reward/ not coerced or bribery
“I feel like a white Mama”—racial other privileged bodies/identities desired? Feel
better about one’ self? Feel worthy
“I feel much more, much better about it.” - feeling better
“like you brush your teeth so that your breath don’t stink, take those pills so that you do
not rot inside”.- integration with daily life
“to know that your health is worth something, you get rewarded for doing a good job
with your health”-feeling proud, feeling one has earned it
“I have to do it better now”- motivated
“I am not undetectable and I do not get my card”- anxiety about being in the program?
feeling coerced??
“talking about your health, taking your medicines, eating properly, resting, and taking
care of your health”-taking care of oneself as part of adherence
“it is like getting the employee of the month”- rightfully earned reward
“Gift card is nice, but my health is more important than a gift card.”—dismissive of
incentive? Social desirability
“You end up looking all hollow, your bones show.”- concern about looks
“if you have to get like cosmetic surgery for the breast or bottom surgery, you have to
be undetectable”- planning for elective surgeries-healthy behavior for that?

“Like Diabetes or any other condition, it takes us longer to heal”- equating HIV with
other chronic disease? Feeling in control?
“I want to live a long and happy life”- desire for longevity
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“I can feel a change, I can feel that I will live and remain healthy”- sense of control on
future
“I have to live for my dream. I have to keep my health to enjoy the life I want, I can’t be
dying every day and trying to make by. I need a complete life. I need these meds to
work for me.”- life goals – adherence a way to achieve them-ensure longevity

“While I am taking the meds I imagine my grandchild’s face”- motivation from family
“I love myself too much to see that happen to me”
“I do not want to end up a walking zombie, a rotten fruit with dry skin over my bones.”looks? Concern about future looks?
“I want to die happy and drunk, not sad and clean”- hopeless and hence careless
“If I do not take the meds I will die”- understanding the role/appreciating the
importance of HAART
“The money comes in handy, you know what I mean. 180 dollars every two weeks is
tight”- appreciating the material aspect
“I do it for myself, for keeping healthy. I know of some who do it for the money”bribery? Social desirability
“No one was holding me responsible, asking me about the pills”- norms before the
VLS
“Too many things to worry about”- barriers

“I now tell everyone please take your pills, you want to live, right?”- looking out for
others in the community
“I took them for some time and then stopped. I was sure nothing will help”hopelessness
“I saw everyone like me living here and Miss A was so helpful.”- love HW, appreciate
the staff
“My partner was in this program, and she told me to join”- enrollment through
family/other community members
“You get the reward, you know, one hundred dollars. You will get good care. It is a
win-win situation”- appreciating VLS-winning for all, so much winning!
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“I am blessed to be a part of this community. I feel I need to give back. I need to tell
those who do not know about HIV, I need to spread the word about good health and
how happy you can be when you are healthy.”- community feeling

“I mean not just take your own medicines but ask others to do it. I want to be a part of
the team” - part of the community, give back to it?
“We can’t stop now. We are so near to the End of AIDS”- movement- advocacyexceeding individual concern to that of the community
“I get some milk and bread when I get the money. I keep the money for emergency”material benefit for times of emergency
“I try to save it up for healthy stuff from Trader Joe’s, it is not possible for me to get
them otherwise”- material benefit-better food
“sometimes I buy stuff that I need around the house. I got a phone, my phone broke so I
got a phone with it. I paid my phone bill the next month”- material benefits, sundry
expenses
“One month I had to pay extra for electricity and I had the card, so used some of that”utilities-material benefits
“I get something big. I got a TV, a blender and a toaster”- luxury goods otherwise too
expensive- material benefits
“What I did, I bought a piece of jewelry with my first gift card something to remember
you know like why I do, what I do”- rewards, self reward, self worth
“I stopped taking my medication. I was selling it”- selling medication for moneybarrier-substance use
“They need their fix and even when the know that my medication is what keeping me
alive, I still want my drugs”
“Even if I am not smoking or doing drugs, sometimes I could use that extra money”-material benefits-patient autonomy
“People forget, people just forget”- forgetting, barrier, demotivated?
“I want to take them every day, like clockwork”- increased self-efficacy
“I just was in the give up stage. I felt that I was going to die anyway”- doubt the
efficacy of medicines/hopeless about future
“I did not want to pop it in front of him”- disclosure issues
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“I wanted to keep my man”- fear of abandonment- barriers
“My partner had died. That is when everything went downhill”- hopelessness, grief
“I have never seen anything like this. The people of here are amazing”-appreciating HW
“They work with you in trying to solve your issues. I absolutely love it here”appreciating HW
“They respect you for what you are and then you want to do that for everyone”community feeling-empowerment-patient dignity
“We are a community of activists here you know”- community feeling, advocacy
impulse
“I always telling them to transfer to Housing Works”- enrollment by word of mouthadvocacy
“I like her (his current PCP) better than my doctor in Philly. I used to see him only a
few times a year, here she keeps me on my toes”- adherence focused care
“I can tell her that I am not taking my meds because I am stressed” -trust and
transparency
“Let me know if you have any trouble with any of the pills. I want you to remain
undetectable and get all the reward cards. I feel she always has my best interests at heart
”- trust in provider, feeling of partnership
“I would forget, just plain forget, but when I started doing this every day, I remember”solution to forgetting
“Here is my pill box, I have taken all the medication you know. This makes a
difference”- tools- pill boxes help with barriers
Concern with side effects
“I have a friend ring me up. I ring her up too. We check on each other -have you taken
the pills? please take them. That’s like having a person care for you”- feeling cared,
community feeling, peer support, self care?
“I love them . I want to be in them, my wife has been featured. Yes, she was very
proud.”- self worth promotion, social marketing

Comparing codes
Feeling happy with HW- Feeling Happy with one’s self-feel worthy
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Feeling rewarded- feeling coerced or bribed
Need to look good- Need to stay healthy- need to be alive for long
Hopelessness- feeling happy with one’s self
Taking care of self- feeling happy- feeling rewarded- hopelessness
Barriers-Appreciating HW services
Feeling rewarded- Motivation
Feeling rewarded- Advocacy- Community feeling
Community feeling- hopelessness
Forgetting – Remembering-Appreciating HW
Trust in provider- Appreciating HW- Barriers
Concern with side effects-trust in provider- feeling rewarded-self efficacy
Material benefits- Feeling rewarded-feel worthy
Taking care- Feeling rewarded- Hopelessness- community feeling
Barriers-Hopelessness- Community feeling

Emergent categories
Self-care
Self-worth
Future orientation
Community feeling
Barriers
Appreciating services
Trust based provider relationship

Final arrangement of themes into theoretical categories as presented in result
Motivation –1. Symbolic (self-worth, self-care, future orientations, community
orientations)
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-2. Material benefits (paying for food, utilities, preventing selling of
medication)
Barriers – Hopelessness, forgetfulness, grief, and personal loss, fear of disclosure, side
effects
Facilitators-Context of Housing Works, patient-provider relationships, intervention
services/tools
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